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ABSTRACT 
 
During the last decades, we have witnessed unparalleled changes in human eating 
habits and lifestyle, intensely influenced by culture and society pressure. Sports practice 
has been strongly implemented in daily routines and visits to the gym peaked driven by 
the indulge in intensive ‘weight loss programs’. Also, the pledge of boasting a healthy 
and beautiful body, all instigate the use of very attractive ‘fat burners’, which are products 
easily available in market, called safe, and known as a quick way to reduce body weight. 
Along with the boosted consumption of all those new formulations that daily appear on 
the market claiming high efficacy on weight loss, the number of reported poisonings also 
increase. A major reason for concern is the fact that the substances listed on these 
product labels are not effectively present in the supplements and it is also frequently 
observed the presence of substances in the formulations that are not labelled at all. One 
eminent example of such substances is 2,4-dinitrophenol (2,4-DNP). 
2,4-DNP is well-known for its weight loss enhancer properties and has been associated 
with a class of the dietary supplements called ‘fat burners’. By interacting with the cellular 
metabolism and increasing muscle definition, 2,4-DNP became very attractive as an 
adjuvant in weight loss processes and attracted the attention of the bodybuilder's 
community. Its interest and use is of highest concern also among adolescents and adults 
who fight overweight. 
Since 1938, 2,4-DNP has been banned as a product for human consumption in many 
countries, due to its adverse effects. The main symptoms associated with 2,4-DNP 
intoxication include hyperthermia, tachycardia, decreased blood pressure and acute 
renal failure, which motivated a worldwide warning issued by the Interpol Anti-Doping 
Unit, reinforcing its dangerousness. Information on the effects of 2,4-DNP mainly derive 
from the intoxication cases reported by the emergency care units, and there is no specific 
antidote or treatment. For these reasons, the development of analytical methods that 
quickly allow the detection and identification of this substance in commercial products 
and in intoxicated individuals is therefore of utmost importance both for forensic and 
clinical purposes. 
In this study, we intended to chemically identify the components of two products 
marketed online as ‘fat burners’ (Supplement 1 and Supplement 2) by gas 
chromatography coupled to mass spectrometry (GC-MS) analysis and to verify the 
presence or absence of 2,4-DNP in these formulations. In addition, we aimed to evaluate 
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the potential hepatotoxicity of these commercial products and compare the elicited 
effects to those of 2,4-DNP. 
Representative samples of capsules of Supplement 1, as well as the capsules included 
in the commercial small plastic bags of Supplement 2 were analysed. The content of the 
capsules was extracted with methanol and subsequent GC-MS investigations identified 
caffeine, glycerol, fatty acids (including 2-palmitoylglycerol or glycerol monostearate) and 
sugars (glucose, sucrose and lactose) as the main constituents. No significant qualitative 
variability was observed in products sold with the same trade name. The comparison 
with the GC-MS data with the authentic analytical standard excluded the presence of 
2,4-DNP in the tested products. Results from the quantitative analysis of caffeine 
contained in the Supplement 2 products show that the daily supplementation indicated 
by the manufacturer exceeds the recommended daily dosage (approximately 400 mg 
versus 848 mg of caffeine per day). 
Furthermore, in vitro bioassays performed for toxicological investigations revealed that 
primary hepatocytes of Wistar rats isolated through a two-step collagenase perfusion 
exhibited a concentration-dependent mortality when exposed to 2,4-DNP at 
concentrations ranging from 549 nM to 10 mM, at 37° C for 24 h, as assessed by three 
viability assays [neutral red uptake assay: EC50 98.05 µM; 3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide  reduction assay: EC50 96.82 µM; lactate 
dehydrogenase leakage assay: EC50 174.83 µM]. These results indicate that the 
mitochondria was the most sensitive organelle to 2,4-DNP-induced toxicity, followed by 
lysosome and by the cytoplasmic membrane. Then, the mechanisms contributing to the 
observed cytotoxicity were scrutinized by exposing cells at 1 μM, 10 μM, 50 μM, 100 μM, 
and 200 µM of 2,4-DNP for 24 h. A significant concentration-dependent increase of 
intracellular reactive species (p<0.01, at ≥50 μM; Dunnett’s test) concurrent to a 
concentration-dependent decline in antioxidant defences [decreased reduced 
glutathione (redGSH; p<0.01, at ≥100 μM; Dunnett’s test); decreased total glutathione 
(p<0.01, at ≥100 μM; Dunnett’s test); increased oxidized glutathione (GSSG; p<0.05, at 
≥1 μM; Dunnett’s test); and decreased redGSH/GSSG (p<0.001, at ≥1 μM; Dunnett’s 
test)]. Significant increase of mitochondrial membrane potential was observed at 10 μM 
and 50 μM (p<0.05; Holm-Sidak’s test), which was in accordance with the exacerbated 
synthesis of adenosine triphosphate (ATP; p<0.0001, at 10–100 μM; Dunnett’s test). 
Energy-dependent instigation of apoptosis was also confirmed by activation of pro-
caspase-8 at all tested concentrations (p<0.05; Dunnett’s test) and by the increased 
activities of caspase-3 and -9, at a concentration of 10 μM on higher (p<0.05; Dunnett’s 
test). 
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In summary, the results presented herein reveal the absence of 2,4-DNP in both tested 
commercially available ‘fat burners’, suggesting that these new formulations of 
Supplement 1 and Supplement 2 are safer from this component. In fact, we prove in this 
work that the consumption of weight loss products containing 2,4-DNP produce 
toxicological effects. According to our results, 2,4-DNP seems to accelerate 
hepatocellular metabolism through instigation of ATP formation at the mitochondria. This 
effect might be responsible by the observed oxidative burst that in turn could activate cell 
death signalling pathways through intrinsic and extrinsic pro-apoptotic mechanisms. This 
information is crucial to reinforce the dangers associated with 2,4-DNP as a substance 
used for weight loss. 
 
Keywords: 
‘Fat Burner’; 2,4-dinitrophenol (2,4-DNP); GC-MS; in vitro hepatotoxicity; primary rat 
hepatocytes; oxidative stress; apoptosis. 
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RESUMO 
 
Nas últimas décadas, os hábitos alimentares têm vindo a sofrer enormes alterações, 
influenciados pelo estilo de vida e devido à pressão exercida por parte da sociedade 
para a obtenção de um corpo aparentemente saudável. O desporto tem sido fortemente 
implementado na rotina diária das pessoas que optam por estilos de vida saudáveis e 
as idas ao ginásio tornaram-se frequentes, muito motivadas por programas intensivos 
de “perda de peso”. Hoje em dia, o prazer de ter um corpo saudável e bonito começa a 
prevalecer sobre as simples “dietas”. Deste modo, e a par com os avanços da indústria, 
todos os dias surgem no mercado novas formulações rotuladas como seguras que 
prometem total eficácia nos resultados obtidos. Estes produtos tornaram-se muito 
aliciantes e o seu consumo tem vindo a aumentar juntamente com o número de relatos 
de intoxicações. O seu perigo é potenciado por não constarem do rótulo os verdadeiros 
constituintes do produto ou por conterem outros que não constam do rótulo. 
Atualmente, o 2,4-dinitrofenol (2,4-DNP) tem vindo a ser associado a uma classe de 
suplementos dietéticos denominados de “queimadores de gordura”, sendo conhecido 
como uma substância potenciadora da perda de peso. Os seus efeitos de interação com 
o metabolismo e o aumento da definição de massa muscular têm estimulado o interesse 
da comunidade de fisiculturistas. No entanto, a sua procura tem-se intensificado por 
parte de adolescentes e adultos que combatem o excesso de peso. Desde 1938 que a 
sua comercialização enquanto produto destinado ao consumo humano foi proibida 
devido aos seus efeitos secundários. Os principais sintomas que estão associados à 
intoxicação por este composto incluem hipertermia, taquicardia, diminuição da pressão 
arterial e falha renal aguda. Recentemente, foi lançado um alerta mundial por parte da 
Unidade Contra a Dopagem da Interpol reforçando a sua perigosidade, atribuindo maior 
ênfase à proibição de comercialização. Os dados existentes sobre os efeitos do 2,4-
DNP provêm apenas dos casos de intoxicação que chegam às unidades de saúde 
hospitalar, não existindo ainda um antídoto ou um protocolo de tratamento estabelecido 
que se possa aplicar. Assim, justifica-se a necessidade de aprofundar o conhecimento 
sobre este composto tornando-se essencial o desenvolvimento de metodologias 
analíticas que permitam a sua deteção e quantificação neste tipo de produtos 
comerciais, para fins clínicos e forenses. 
Um dos objetivos deste estudo passou por identificar quimicamente os componentes 
presentes em dois produtos comercializados online como “queimadores de gordura” 
(Suplemento 1 e Suplemento 2), recorrendo à técnica de cromatografia gasosa acoplada 
à espetrometria de massa (GC-MS), de modo a verificar a presença ou ausência de 2,4-
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DNP nestas formulações. Este trabalho destinou-se ainda a avaliar os efeitos 
hepatotóxicos destes mesmos produtos e do 2,4-DNP individualmente, usando cultura 
primária de hepatócitos de rato Wistar como modelo in vitro. 
A análise por GC-MS é considerada uma metodologia analítica altamente sensível e foi 
aplicada para avaliar a composição real destes dois “queimadores de gordura”. Foi 
analisado o conteúdo de uma amostra representativa das cápsulas de Suplemento 1 
bem como de algumas das cápsulas contidas nas saquetas de Suplemento 2. O 
conteúdo das cápsulas foi extraído com metanol e os principais compostos identificados 
por GC-MS foram: cafeína, glicerol, ácidos gordos (incluindo 2-palmitoilglicerol e glicerol 
monostearato) e açúcares (glucose, sacarose e lactose). O conteúdo dos produtos 
mostrou-se semelhante entre eles, não apresentando variabilidade entre amostras do 
mesmo produto. A possibilidade da existência de 2,4-DNP foi excluída por comparação 
com a análise do respetivo padrão analítico. Considerámos relevante efetuar a 
quantificação da cafeína e os resultados mostraram que a toma diária sugerida no rótulo 
do produto Suplemento 2 excede a dose diária recomendada (aproximadamente 400 
mg versus 848 mg de cafeína por dia). 
Os ensaios in vitro destinaram-se a avaliar a citotoxicidade e revelaram que os 
hepatócitos primários de rato Wistar, isolados através de uma perfusão com colagenase, 
exibiam uma mortalidade dependente da concentração quando expostos a 
concentrações de 2,4-DNP que variaram entre 549 nM e 10 mM, a 37°C durante 24 h, 
conforme avaliado em três ensaios de viabilidade [ensaio de absorção de vermelho 
neutro: EC50 98.05 µM; ensaio de redução do brometo de 3-(4,5-dimetiltiazol-2-il)-2,5-
difeniltetrazólio: EC50 96.82 µM; ensaio da lactato desidrogenase: EC50 174.83 µM]. 
Estes resultados indicam que a mitocôndria foi o organelo mais sensível à toxicidade 
provocada pelo 2,4-DNP, seguido do lisossoma e da membrana plasmática. 
Seguidamente, os mecanismos que contribuíram para a citotoxicidade observada foram 
examinados por exposição das células a concentrações de 1 µM, 10 µM, 50 µM, 100 
µM e 200 µM de 2,4-DNP, durante 24 h. Verificou-se um aumento significativo da 
dependência da concentração de espécies reativas intracelulares (p˂0.01, ≥50 µM; teste 
de Dunnett) com consequente diminuição das defesas antioxidantes dependente da 
concentração [diminuição da glutationa reduzida (GSH reduzida; p˂0.01, ≥100 µM; teste 
de Dunnett), diminuição da glutationa total (p˂0.01, ≥100 µM; teste de Dunnett), 
aumento da glutationa oxidada (GSSG; p˂0.05, ≥1 µM; teste de Dunnett) e diminuição 
da razão GSH reduzida/GSSG (p˂0.001, ≥1µM; teste de Dunnett)]. Observou-se um 
aumento significativo do potencial de membrana mitocondrial nas concentrações de 10 
µM e 50 µM (p˂0.05; teste de Holm-Sidak) que se apresenta de acordo com a síntese 
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aumentada de adenosina trifosfato (ATP; p˂0.0001, 10–100 µM; teste de Dunnett). O 
aumento da apoptose, dependente de energia, também foi confirmado pela ativação da 
pró-caspase-8 em todas as concentrações testadas (p˂0.05; teste de Dunnett) e pelo 
aumento da atividade das caspases -3 e -9 para concentrações superiores a 10 µM 
(p˂0.05; teste de Dunnett). 
Em resumo, estes resultados revelam a ausência de 2,4-DNP em ambos os 
“queimadores de gordura” analisados. De acordo com os resultados obtidos neste 
estudo, o 2,4-DNP parece acelerar o metabolismo hepatocelular atuando como 
promotor da formação de ATP nas mitocôndrias. Este efeito pode justificar o dano 
oxidativo observado in vitro que, por sua vez, poderá ativar os processos de sinalização 
de morte celular através de mecanismos pró-apoptóticos intrínsecos e extrínsecos. Esta 
informação é crucial para reforçar os perigos associados ao 2,4-DNP enquanto 
substância usada para a perda de peso. 
 
Palavras-chave: 
“Queimador de gordura”; 2,4-dinitrofenol (2,4-DNP); GC-MS; hepatotoxicidade in vitro; 
hepatócitos primários de rato; stress oxidativo; apoptose. 
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PART 1 – INTRODUCTION
  
2 
1.1. The problem of ‘fat burners’ 
Several changes have been occurring in society regarding dietary habits. Physical 
exercise and a strong adhesion to sports requiring strength have promoted the search 
for all types of supplementation that may include drugs and drugs of abuse (Petróczi et 
al., 2015). The constant dissatisfaction with physical stature and body is proving to be 
an ‘epidemic’ issue. This happened with the concern to fight obesity, which has also 
increased. Therefore, with the advances of the industry and the constant need to respond 
to the search for these supplements, new formulations labelled as safe and promising 
total effectiveness in the reduction of body weight appear on the market. These products 
have become very attractive to be included in weight loss programs, and to be used by 
those who practice sports and competitions that require greater body strength and to 
bodybuilders.  
The most popular supplements for weight loss are the ‘fat burners’ that are used as 
weight loss promoters by inducing a greater oxidation of fat during the performance of 
physical exercise. The main physiological effects induced by ‘fat burners’ include an 
increase of fat oxidation during exercise, suppress appetite, increase weight loss, 
prevent weight gain after weight loss, impair fat absorption and increase fat metabolism 
and energy expenditure (figure 1). 
 
 
 
Figure 1: The interaction of ‘fat burners’ on increasing fat metabolism and promoting weight loss, 
adapted from Jeukendrup and Randell (2011). 
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However, many users of these type of supplements often believe that there is no need 
to associate the consumption of these substances with any type of physical activity or 
diet. In addition to their potential in fat loss, they have also been attributed the ability to 
promote muscle gain mass (Lee et al., 2014). These supplements can be purchased on 
the internet or in stores that sold sports supplementation. 
These products can be combined with plans for physical exercise, diet and behavioural 
therapies, and are often integrated into a therapeutic scheme that involves a reduction 
in appetite, a false increase in satiety and a reduction in nutrient absorption (Ioannides-
Demos et al., 2011). Generally, these supplements contain a combination of substances 
whose main action is the increase of the metabolic rate. The most popular products 
include caffeine, carnitine, green tea, conjugated linoleic acid (mixture of isomers), 
Coleus forskohlii extract, chromium and fucoxanthin (Jeukendrup and Randell, 2011). 
However, it has often been found that not all constituents of commercial products are 
mentioned on the label. In fact, labelling problems have been reported in many 
supplements available because they are adulterated with mixtures of other substances 
(da Justa Neves and Caldas, 2015). Many of these substances are of legal use but are 
unsafe at the concentrations in which they are used, others are of illegal use, as steroids 
(Pomeranz et al., 2015). Therefore, there is uncertainty and danger regarding the use of 
these supplements that refrain health professionals from their prescription. On the other 
hand, their commercialization is not restricted to medical prescription, providing the 
opportunity to commercialize non-prescription products (Blanck et al., 2007). 
 
1.2. Trends in 2,4-dinitrophenol (2,4-DNP) use 
Dinitrophenols are a family of synthetic organic compounds that exist in the solid state, 
with crystalline structure and yellow color (Harris and Corcoran, 1995; Miranda et al., 
2006). They have a high degree of toxicity and can be absorbed by the skin, oral, and 
inhalation routes (Risikobewertung, 2015). 2,4-Dinitrophenol (2,4-DNP) is one of the 
isomers belonging to this family of compounds. It began to be applied in the manufacture 
of ammunition and explosives during the First World War, having been used as food and 
textile dye, wood preservative and agricultural pesticide. It was in the year of 1933 that 
its potentialities associated with the loss of weight were discovered, having begun its 
commercialization without medical prescription (Grundlingh et al., 2011; Janz, 2005; Lee 
et al., 2014). However, in 1938 it was considered unfit for human consumption because 
of its toxicity by the Food and Drug Administration (FDA) in the United States of America 
(USA) and afterwards, only in 2003, by the Food Agency in the United Kingdom (UK) 
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(Türkay et al., 2014). An alert was issued by the Interpol in 2015 in collaboration with the 
World Anti-Doping Agency which reinforced the dangers associated with the use of this 
compound (Agency, 2015; Costa, 2015; INTERPOL, 2015). Over all these years, deaths 
have been attributed to the ingestion of this dangerous substance, and in many cases 
were associated with the ambition of body fat loss (Veloso, 2013). 
The following sections present a bibliographic review of 2,4-DNP about legislation and 
epidemiology; chemical structure, physicochemical properties and commercial 
presentation; pharmacokinetics; pharmacodynamics; toxic effects, diagnosis and 
treatment associated with intoxication, as well as analytical methodologies for the 
determination of 2,4-DNP in commercial products and biological matrices. The literature 
search was carried out using the PubMed database using the words 2,4-dinitrophenol 
weight loss, obtaining a total of 35 articles and 2,4-dinitrophenol toxicity with a total of 
264 articles, until January 2017. Only papers related to exposure and effects in humans 
were considered as well as those that included analytical methods of analysis. 
Information (up to the same dates) was also collected on websites using the Google 
search engine. 
 
1.3. Legislation and epidemiology 
The data on the prevalence of use of 2,4-DNP are scarce, especially at the European 
level. In Portugal, legislation prohibits its use in cosmetic products but authorizes its 
commercialization as a pesticide and it is included in the ‘List of pesticide products’ 
authorized for sale (Veterinária, 2015). Most of the information available in the literature 
on the use of this substance and associated toxicity comes from the USA and UK. In the 
USA, reports of the occurrence of death from intoxication with 2,4-DNP, in 1938 led to 
the first alert that contemplated this compound and labelled it as ‘unfit for human 
consumption’, labelling it as ‘extremely dangerous’. Also in the same year, the US 
Environmental Protection Agency (EPA) published it on the list of hazardous air 
pollutants, and warned of the need to prohibit its commercialization in pesticides 
products, since this compound could be legally marketed as a pesticide (Harris and 
Corcoran, 1995; Zaharia et al., 2016). Currently, this supervision is performed by the 
FDA (Administration, 2008). In Europe, only in 2003, the UK Food Standards Agency 
(FSA) issued a warning to the public not to consume any product containing 2,4-DNP in 
its constitution, also labelling it ‘unfit for human consumption’ (Zaharia et al., 2016).  
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Recently, 110 websites, among a reference of 4402, that commercialize 2,4-DNP as a 
‘fat burner’ have been detected. This inspection action was carried out by the FDA and 
its main objective was to combat the illicit manufacture and marketing of this product in 
order to remove it from the market (Administration, 2016). Despite all this supervision 
and successive warnings and bans already issued, this compound is not yet listed on 
international regulatory bodies such as the World Health Organization (WHO) or the 
United Nation Environment Program (UNEP) (Zaharia et al., 2016). Table 1 lists the 
entities that have regulated this compound for human use. 
 
Table 1: Entities that regulated the use of 2,4-DNP (2,4-dinitrophenol).  
Year Country Entity Regulation 
1938 USA FFDCA Prohibition 
1938 USA US EPA Prohibition 
2003 UK UK FSA Prohibition 
2008 Portugal 
Department of Health (Decreto-Lei n.° 
189/2008) 
Prohibition 
2015 Portugal 
Department of Agriculture – List of 
pesticide products (Veterinária, 2015) 
Authorization 
Legend: FFDCA – Federal Food, Drug, and Cosmetic Act; UK – United Kindom; USA – United States of 
America; EPA – Environmental Protection Agency; FSA – Food Standards Agency. 
 
Regarding the available data on the epidemiology and number of deaths related to this 
compound, figure 2 represents data between the years of 1910 and 2010, reported in a 
study that compiled all cases of fatal poisonings until 2010 described in the literature 
(Grundlingh et al., 2011). 
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As can be depicted in figure 2, the highest prevalence occurred between 1910 and 1920, 
which coincides with its use as a dye in the textile industry, as a pesticide in agriculture, 
and as a wood preservative. The routes of exposure, in these cases, are dermal and 
inhalation, and are therefore associated with unintentional exposures. After this period, 
and in the subsequent decade, there was no report of 2,4-DNP inducing intoxications 
(Grundlingh et al., 2011). From 1931 and in the following two decades there was a 
record, although not so significant, of deaths associated with this compound, after 
Maurice Tainter discovered its potential as a ‘fat burner’ (Grundlingh et al., 2011; Tainter 
et al., 1933). In 1981, in Texas, the physicist Bachynsky developed a formula named 
‘Mitcal’, whose main constituent was 2,4-DNP, and began marketing it at the clinic where 
he worked. This product was intended to be part of an intracellular temperature elevation 
therapy. Its adverse effects on the patients were reported, with the first death occurring 
in 1984. Consequently, the FDA banned the sale of this formulation (Grundlingh et al., 
2011). In the first decade of the 21st century, 2,4-DNP appears again in media such as 
the internet, blogs dedicated to bodybuilding, but also blogs dedicated to nutrition. Initially 
it began to be referred to as ‘promise for weight loss and for increasing muscle definition’ 
but quickly its harmful effects on health and its relationship with irreversible intoxications 
became relevant. In 2015, the Interpol issued an alert to reinforce the dangers associated 
Figure 2: 2,4-DNP (2,4-dinitrophenol) related deaths, between 1910 and 2010, 
obtained from the research of all cases reported in the literature up to 2010 
(Grundlingh et al., 2011). 
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with the ingestion of this compound (INTERPOL, 2015). Despite all the prevention 
measures and alerts issued, the demand for this type of products has increased. Table 
2 summarizes the cases of death from intoxication with 2,4-DNP, occurring between 
1916 and 2016, available in the scientific literature. 
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Table 2: Summary of published fatalities between 1916 and 2016, relating to exposure to 2,4-DNP (2,4-dinitrophenol), adapted from Grundlingh et al. (2011). 
Sex Age Type of exposure Dose Time to death 
Maximum 
temperature (°C) 
Year Reference 
M Unknown Occupational Unknown 14 h 40.5 1916 (B., 1916) 
M Unknown Occupational Unknown Unknown Unknown 1918 (Warthin, 1918) 
36 workers Unknown Occupational Unknown Unknown 43 1919 (Roger, 1919) 
M Unknown Weight loss 2.5–5 g 10 h >43 1933 (Geiger, 1933) 
F 46 Weight loss 
0.3 g over 6 
weeks 
Unknown 40.4 1934 
(William and L., 
1934) 
F 31 Weight loss 6.06 g in 4 days 16 days after start of trial 38.9 1934 
(Masserman and 
Goldsmith, 1934) 
F 25 Weight loss 2.88 g over 5 days 7 days after first dose 38.9 1934 
(Poole and 
Haining, 1934) 
F Unknown Weight loss 10 g over 6 weeks 5 days after admission 41 1934 (Silver, 1934) 
M 37 Weight loss 9 g over 7 days 11 h 40.9 1934 (Tainter, 1934) 
F 13 Weight loss 5.4 g over 46 days 20 h after admission 40.9 1936 
(Goldman and 
Haber, 1936) 
F 21 Weight loss 4.5 g 9 h 41.1 1936 (Purvine, 1936) 
M Unknown Intentional Unknown 12 h Unknown 1953 (Swamy, 1953) 
M 61 Accidental Unknown 24 h Unknown 1960 
(Cann and 
Verhulst, 1960) 
F 17 Weight loss Unknown 28 h 38.5 2002 
(Pace and Pace, 
2002) 
M 22 Weight loss 2.4 g over 4 days 17 h after last dose 38.9 2004 
(McFee et al., 
2004) 
F 17 Intentional 2.3 g–2.88 g 10 h >40 2005 
(Hsiao et al., 
2005) 
M 24 Bodybuilding Unknown Unknown 40.8 2005 
(Suozzi et al., 
2005) 
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Sex Age Type of exposure Dose Time to death 
Maximum 
temperature (°C) 
Year Reference 
F 17 Bodybuilding Unknown 3 h after presentation 39.4 2006 
(Miranda et al., 
2006) 
M 28 Bodybuilding Unknown 50 min after presentation 41.1 2006 
(Miranda et al., 
2006) 
M 30 Bodybuilding Unknown Unknown Unknown 2007 
(Politi et al., 
2007) 
F 27 Weight loss Unknown 8 h after presentation 38 2009 
(Tewari et al., 
2009) 
M 46 Intentional 2.8 g 21 h 37.8 2010 
(Bartlett et al., 
2010) 
M Unknown Intentional 2.8 g 15 h 39.5 2010 
(Siegmueller and 
Narasimhaiah, 
2010) 
F 49 Occupational Unknown 15 h 38.9 2011 
(Jiukun et al., 
2011) 
M 41 Occupational Unknown 9 h 38.5 2011 
(Jiukun et al., 
2011) 
F 23 Weight loss Unknown Unknown Unknown 2012 
(Brooke, 2013; 
Zaharia et al., 
2016) 
M 18 
Weight 
loss/Bodybuilding 
Unknown Unknown Unknown 2013 
(Watson, 2013; 
Zaharia et al., 
2016) 
M 30 
Weight 
loss/Bodybuilding 
≤1.8 g 15 h 42.9 2014 
(Türkay et al., 
2014) 
F 21 Weight loss Unknown Unknown Unknown 2015 
(Ward, 2015; 
Zaharia et al., 
2016) 
M 50 Weight loss 12.3 g 9 h Unknown 2016 
(Zack et al., 
2016) 
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By analysing the table, one can associate the demand for this compound with the 
purpose of weight loss and to a younger aged group. However, there is also some 
adherence by individuals of other ages in the process of weight loss. 
A study published by Kamour et al. in 2014, which collected data from 1 January 2007 
to 31 December 2013 in the UK, based on consultations carried out by telephone and 
through the accesses registered on the TOXBASE platform (toxicological database), 
revealed the growing trend for interest and search for information on 2,4-DNP that 
probably increased the number of cases of toxicity. Figure 3 shows these data (Kamour 
et al., 2014). 
 
 
 
 
 
 
 
 
 
 
 
 
 
To counteract the number of intoxications, authorities in the UK have taken many 
preventive actions in 2013, consisting of police warnings, local authorities control of sales 
on the internet, public outreach actions at gyms, and also by sending letters addressed 
to family doctors and emergency medical departments with information on 2,4-DNP. 
Because of these measures, the number of cases of intoxication by 2,4-DNP apparently 
decreased between the end of 2013 and the beginning of 2014, alongside with a 
decrease in the number of telephone and database information search records (figure 
4). In the period of 2014/2015 there were 13 cases related to the toxicity of 2,4-DNP, at 
Figure 3: Registration of telephone consultations and access data for TOXBASE 
between January 2007 and December 2013 for 2,4-DNP (2,4-dinitrophenol) 
(Kamour et al., 2014). 
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least one of these cases being a fatal poisoning. However, the chart shows a new trend 
for the increase in the number of 2,4-DNP-related surveys (telephone and database) 
from 2015, which may mean that its use will again increase (Thomas and Duarte-
Davidson, 2015). 
 
 
 
During the year of 2015, the authorities continued the warning measures already 
promoted in 2013, with a greater focus on physicians of the emergency medical 
departments and the supervision of internet sales. Because of these initiatives, the 
number of surveys (telephone and database) declined again, meaning a possible 
decrease in use (figure 5) (Thomas and Duarte-Davidson, 2016). 
 
 
 
Figure 4: Registration of telephone consultations and TOXBASE access data of 2,4-DNP (2,4-
dinitrophenol) from January 2011 to March 2015 (Thomas and Duarte-Davidson, 2015). 
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From the data published in this study it is concluded that in the UK, since 2008, at least 
77 cases of intoxication associated with telephone contacts have occurred, 11 of which 
corresponded to fatal poisonings and, of these, 6 occurred in 2015. These data confirms 
the increase in the use of 2,4-DNP in 2015 in the UK (Thomas and Duarte-Davidson, 
2016). It is generally concluded from all these reports that preventive and warning 
measures for the most vulnerable population, as well as for health professionals, have a 
positive effect on trends in the consumption of potentially hazardous substances such 
as 2,4-DNP. 
 
1.4. Chemical structure, physicochemical properties and commercial presentation 
The molecular formula of 2,4-DNP is C6H4N2O5 and its chemical structure is represented 
in figure 6 (Petróczi et al., 2015; TOXNET). 
 
Figure 5: Registration of telephone consultations and access data to TOXBASE, with 
relevance starting in the first quarter of 2015 (Thomas and Duarte-Davidson, 2016). 
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As mentioned before, 2,4-DNP is one of the isomers belonging to the family of 
dinitrophenols, a class of organic compounds of synthetic origin (Miranda et al., 2006). 
Table 3 summarizes some of the physicochemical properties of 2,4-DNP (TOXNET). 
 
 
 
 
 
Legend: CAS – Chemical Abstracts Service. 
 
In addition to this designation, this substance can also appear as 2,4-DNP, dinitrophenol 
or, simply, DNP. It is marketed in the form of cream, powder, tablets or capsules. In this 
last case, it is common for capsules to contain between 100-200 mg of compound or to 
be mixed with thyroxine or anabolic steroids (Grundlingh et al., 2011; INTERPOL, 2015; 
Türkay et al., 2014). Online sales began by being masked with different names 
associated, such as Sulfo/Solfo Black, Nitro Kleenup or Caswell No.392, Aldifen, 
Chemox, Nitophen, Dinofan, Dinosan, Dnoc, Osmotox PRB, Fenoxyl PRB or 
Tertosulphur PRB. Some of these variants may also be listed on the label of dietary 
supplements intended for weight loss (Petróczi et al., 2015). Nowadays, when searching 
the internet through the Google search engine, it is verified that these designations are 
associated with the theme of weight loss and muscle mass definition. Table 4 shows 
some examples of commercial products allegedly containing 2,4-DNP in their 
composition. 
Table 3: Physicochemical properties of 2,4-DNP (TOXNET).  
Physicochemical Properties 
Molecular weight 184.106 g/mol 
Melting point 114.8 °C 
Dissociation constant pKa = 4.09 
Partition Coefficient logP = 1.67 
CAS number 51-28-5 
Figure 6: Chemical structure of 2,4-DNP (2,4-dinitrophenol) 
(TOXNET). 
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Table 4: Products containing 2,4-DNP (2,4-dinitrophenol) commercialized online. 
Product Webpage address 
 
http://evunsarep.4sql.net/sale/307-dnp-x-fat-
burner/ [accessed 15 January 2017] 
 
http://www.shemazing.net/tag/diet-pills/ [accessed 15 
January 2017] 
 
https://www.vaultekpharma.com/index/weigth-
loss_fat-burners.html [accessed 15 January 2017] 
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Product Webpage address 
 
https://www.steroid.com/DNP.php [accessed 15 January 
2017] 
 
http://www.dailymail.co.uk/news/article-
2282158/Student-Sarmad-Alladin-18-known-Mr-
Muscles-dies-taking-DNP-fat-burning-pills.html 
[accessed 15 January 2017] 
 
http://www.dziennikzachodni.pl/artykul/919736,dnp-
burner-dinitrofenol-odchudzanie-smiertelne-
niebezpieczny-srodek-na-odchudzanie,id,t.html 
[accessed 15 January 2017] 
 
http://www.dziennikzachodni.pl/artykul/zdjecia/9197
36,dnp-burner-dinitrofenol-odchudzanie-smiertelne-
niebezpieczny-srodek-na-
odchudzanie,2056431,id,t,zid.html [accessed 15 January 
2017] 
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Product Webpage address 
 
http://www.dziennikzachodni.pl/artykul/zdjecia/9197
36,dnp-burner-dinitrofenol-odchudzanie-smiertelne-
niebezpieczny-srodek-na-
odchudzanie,2056443,id,t,zid.html [accessed 15 January 
2017] 
 
 
1.5. Pharmacokinetics 
2,4-DNP may be absorbed in the gastrointestinal tract, when ingested, in the lungs, when 
inhaled, and through the skin. After absorption, it is transported through the bloodstream 
to organs and tissues such as the liver and kidneys. Because it is a lipophilic and low 
molecular weight compound it is rapidly absorbed by passive diffusion. In the stomach, 
this process occurs in its non-ionized form because it is an acidic compartment (pKa of 
2,4-DNP: 4,09). In the bloodstream of 2,4-DNP binds in part to plasma proteins while 
another portion remains in circulation. It is this fraction that reaches the organs and 
tissues, exerting toxic effects. 
It is mainly metabolized by a reduction reaction that occurs in its nitro groups, forming 
metabolites of lower toxicity in rat liver homogenates represented in figure 7 (Harris and 
Corcoran, 1995). 
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The nitroreductase enzymes responsible for this process are microsomal and cytosolic 
(where they have the highest activity) and use nicotinamide adenine dinucleotide 
phosphate (NADPH) as a cofactor. The resulting metabolized compounds are 4-amino-
2-nitrophenol, 2-amino-4-nitrophenol and 2,4-diaminophenol (Harris and Corcoran, 
1995). A study performed by Eiseman et al. indicates that 2-amino-4-nitrophenol is the 
most abundant metabolite in rat liver homogenates (Eiseman et al., 1972). 
The elimination of the metabolites and of part of the main compound that did not undergo 
metabolization occurs preferentially through the urine and it is excreted by passive 
diffusion (Harris and Corcoran, 1995). 
 
1.6. Pharmacodynamics 
2,4-DNP acts as an uncoupler agent for mitochondrial oxidative phosphorylation. Its 
intracellular target is the mitochondria, the organelle responsible for cellular respiration, 
interfering with oxidative phosphorylation in the Krebs cycle. In the presence of 2,4-DNP, 
the energy released during the oxidation-reduction reactions, by the consequent 
transport of electrons, is not able to potentiate the process of adenosine triphosphate 
(ATP) production (Zaharia et al., 2016). 
Figure 7: Metabolic pathway of 2,4-DNP (2,4-dinitrophenol) in rat liver homogenates, 
adapted from Harris and Corcoran (1995). Legend: NADPH – Nicotinamide Adenine 
Dinucleotide Phosphate. 
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2,4-DNP acts to block the absorption of inorganic phosphate (PI) which, consequently, 
prevents its addition by ATP synthase to adenosine adipose phosphate (ADP) molecules 
(figure 8) (Hargreaves et al., 2016). 
 
 
The final production of ATP by the cell is negatively influenced and leads to an inhibition 
of all biological processes that require energy. Additionally, it causes a change in the 
electrochemical proton gradient by increasing permeability for its passage out of the cell 
(Grundlingh et al., 2011). Thus, there is a decrease in energy efficiency, potentiated by 
an increase in the permeability of the membrane to the protons and by the impossibility 
of converting ADP to ATP. Energy dissipation is then promoted in the form of heat which 
enhances a rapid increase in metabolism and a higher calorie consumption than usual. 
Thus, there is a strong inhibition of the cellular respiration process. However, the 
accumulation of potassium continues and the inorganic phosphate ceases to be 
absorbed by the mitochondria and remains accumulated (Zaharia et al., 2016). 
 
1.7. Toxic effects, diagnosis and therapy associated with intoxication 
Available data on the effects of 2,4-DNP come from reports of patients arriving at 
emergency medical facilities. The most frequently described symptoms are nausea, 
vomiting, sweating, tachycardia, hyperthermia, confusion, agitation, breathing difficulties, 
Figure 8: The mechanism by which 2,4-DNP (2,4-dinitrophenol) induces uncoupling of oxidative 
phosphorylation at the inner mitochondrial membrane (Hargreaves et al., 2016). Legend: ADP – 
Adenosine Diphosphate; ATP – Adenosine Triphosphate; Pi – Inorganic Phosphate. 
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back and abdominal pain (Bartlett et al., 2010; Grundlingh et al., 2011; Siegmueller and 
Narasimhaiah, 2010; Zack et al., 2016). However, there are other visible external signs 
related to the change in color and texture of the skin, namely, the appearance of a yellow 
color and rashes. Acute renal failure is another serious consequence associated with 
this level of toxicity, evidenced by the existence of tubular necrosis observed in the 
autopsy of fatal cases (Grundlingh et al., 2011). 
There is yet no guideline available for the treatment of 2,4-DNP poisoning. This treatment 
should therefore be performed symptomatically taking into account the symptoms that 
the patient is manifesting (Zack et al., 2016). To facilitate the elimination of the 
compound, the administration of activated charcoal can be considered (Grundlingh et 
al., 2011; Türkay et al., 2014). Hyperthermia can be minimized by cooling the body 
through cold baths, administration of benzodiazepines, or dantrolene (currently under 
study) (Lee et al., 2014; Zack et al., 2016). Anxiety and agitation can also be treated with 
the administration of benzodiazepines (Grundlingh et al., 2011; Türkay et al., 2014). To 
verify possible changes in the state of consciousness, it is common to use the Glasgow 
Coma Scale (Türkay et al., 2014). In cases involving cardiorespiratory arrest situations, 
professionals may follow the guidelines of the European Resuscitation Council (Nolan et 
al., 2015). 
 
1.8. Analytical methods for 2,4-dinitrophenol (2,4-DNP) determination in 
commercial products and biological matrices 
The determination of 2,4-DNP in commercial products is possible using liquid or gas 
chromatography separation techniques and using different detectors [Flame Ionization 
Detector (FID), Ultraviolet-visible (UV-VIS), Diode Array Detector (DAD), Mass 
Spectrometry (MS)]. Samples of suspected tablets may be analyzed by High 
Performance Liquid Chromatography coupled to DAD (HPLC-DAD), Liquid 
Chromatography coupled to MS and Time-of-Flight (LC-MS-TOF) or Gas 
Chromatography coupled to MS (GC-MS) to identify and quantify 2,4-DNP in the 
presence of other compounds (Lee et al., 2014) (Miranda et al., 2006). The determination 
of 2,4-DNP in biological matrices (blood and urine) is usually carried out by LC-MS 
(Miranda et al., 2006; Politi et al., 2007; Robert and Hagardorn, 1983). Table 5 
summarizes the most used analytical techniques. 
 
20 
 
Table 5: Analytical methods used to determine 2,4-DNP (2,4-dinitrophenol) in different samples. 
Sample Sample preparation Separation method 
Detection 
method 
Reference 
Capsule 
--- 
LC 
GC 
LC 
DAD 
MS 
TOF/MS 
(Lee et al., 
2014) 
SPE with methanol solution (1 mg/mL). 
GC 
LC 
MS 
DAD 
(Miranda et al., 
2006) 
Stock solutions were prepared in methanol (0.5 mg/mL). 
Dilution of standard working solution was prepared in methanol 
(12.5 µg/mL). 
Example: powder was prepared in pure acetonitrile. 
The suspension obtained was mechanically stirred, sonicated 
and centrifuged. Filtration: through a 0.45 µm pore size GH 
Polypro (GHP) membrane filter. 
LC DAD 
(Rebiere et al., 
2012) 
Blood 
Liquid/Liquid extraction: extraction with n-butyl chloride. LC DAD 
(Miranda et al., 
2006) 
Without previous sample preparation. 
Addition of internal standard (3,5,6-d3-2,4-dinitrophenol) solution 
in methanol; drying under nitrogen flow; deproteinization with 
acetonitrile; vortex mixing and centrifugation. Dilution of the 
supernatant with formic acid (0.1%). 
LC MS 
(Politi et al., 
2007) 
Liquid/Liquid extraction: dilution of samples with saline; 
addiction of distilled water containing of 3,5,6-d3-2,4-
dinitrophenol; acidification with citrate buffer (pH = 3, 
citrate/phosphate buffer) and extraction with diethyl ether; 
counter-extraction with 5% aqueous NaHCO3. Acidification with 
HCl and re-extraction with diethyl ether. The organic phase was 
dried with anhydrous sodium sulphate; evaporation of diethyl 
ether at 60⁰C under nitrogen flow. Reconstitution with benzene. 
GC MS 
(Robert and 
Hagardorn, 
1983) 
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Sample Sample preparation Separation method 
Detection 
method 
Reference 
Blood 
Liquid/Liquid extraction with 3,5,6-d3-2,4-dinitrophenol as 
internal standard. 
Derivatization with BSTFA + 1% TMCS. 
GC MS 
(Fogelberg, 
2012) 
Urine 
--- GC MS 
(Miranda et al., 
2006) 
Without previous extraction. 
Addiction of urine to internal standard (3,5,6-d3-2,4-
dinitrophenol). Dilution of the sample in formic acid (0.1%). 
LC MS 
(Politi et al., 
2007) 
River water 
SPE: filtration of the river water through a 0.45 µm filter; 
acidification to pH 2 with hydrochloric acid (1 M). Elution with 
acetone and evaporation under a nitrogen flow. 
Derivatization: addiction of 10% aqueous potassium carbonate 
and acetone solution of 5% PFBBr reagent. Evaporation to 100 
mL under a nitrogen flow. Addiction of dichloromethane and the 
organic phase was washed with mili-Q-purified water. 
GC MS 
(Nakamura et 
al., 2001) 
Precipitation 
water 
Liquid/Liquid extraction: acidification with H2SO4 to pH 2, 
extraction in a rotary perforator with a pentane/ether mixture 
(5:1) (v/v). Separation of organic phase, dried over Na2SO4 and 
concentration to 0.5 mL. 
Derivatization: addition of cooled etheric diazomethane 
solution. Concentration in the rotary evaporator. 
GC 
NPD 
MS 
(Nick and 
Schöler, 1992) 
Water 
SPME: extraction for 30 min with a polyacrylate coated fiber 
(desorption time was 3 min at 270°C); acidification with H2SO4 to 
pH 2. 
GC MS 
(Lu et al., 
1999) 
Legend: BSTFA – N,O-Bis(trimethylsilyl)trifluoroacetamide; DAD – Diode Array Detector; GC – Gas Chromatography; GHP – GH Polypro; LC – Liquid Chromatography; MS – 
Mass Spectrometry; NPD – Nitrogen Phosphorus Detector; PFBBr – Pentafluorobenzyl Bromide; SPE – Solid/Liquid Extraction; SPME – Solid-phase microextraction; TMCS – 
Trimethylsilyl chloride; TOF – Time-of-Flight. 
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In general, when the GC technique is used, 2,4-DNP should be extracted from the matrix, 
either by liquid-liquid extraction (Fogelberg, 2012; Mathers et al., 2007; Nick and Schöler, 
1992; Politi et al., 2007; Robert and Hagardorn, 1983), or by solid-phase extraction (SPE) 
(Nakamura et al., 2001). The compound will have to be extracted with an organic solvent 
to be injected into the GC. To improve the chromatographic performance, it is possible 
to use derivatization by fluoroacylation with N, O-bis(trimethylsilyl)trifluoroacetamide 
(BSTFA) as reported by Fogelberg et al. (2012) and Mathers et al. (2007). Another 
methodology recommended in GC is the solid-phase microextraction (SPME), where the 
compound passes to the gas phase and it is subsequently adsorbed onto a fiber with a 
certain polarity, and then desorbed in the chromatograph injector (Lu et al., 1999). In the 
case of the use of the HPLC technique, a prior concentration of the compound using 
SPE before injecting it directly into the LC. 
In summary, and as can be seen in Table 5, to be able to apply these analytical methods 
it is essential to carry out a previous process of treatment of the sample when analyzing 
the compounds of this family. This is mainly due to its high polarity and volatility that 
affect its chromatographic resolution. Thus, when the compounds have these 
characteristics they will have to undergo a pretreatment process (Mahugo Santana et 
al., 2009), which is usually carried out using extraction techniques followed by a 
derivatization procedure (Nick and Schöler, 1992) in which the most widely used 
derivative agent is BSTFA (Fogelberg, 2012; Mathers et al., 2007) although 
pentafluorobenzyl bromide (PFBBr) may also be used as an alternative (Nakamura et 
al., 2001). SPE (Nakamura et al., 2001); SPME (Lu et al., 1999) and liquid-liquid 
extraction (Fogelberg, 2012; Mathers et al., 2007; Nick and Schöler, 1992; Politi et al., 
2007; Robert and Hagardorn, 1983) after acidification, are the most common extraction 
methodologies found in the literature. 
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PART 2 – OBJECTIVES 
 
The ‘fat burners’ belong to a popular group of nutrition supplements that improve fat 
metabolism, energy expenditure and increase fat oxidation during exercise. These 
supplements may contain many ingredients, each one with its own mechanism of action, 
the combination of these substances is claimed to have additive effects. One of such 
constituents used in weight loss products is 2,4-DNP. Although it has been banned as a 
product for human consumption, one must consider the possibility of 2,4-DNP being 
illicitly included in ‘fat burners’ formulations. Therefore, one of the main objectives of 
this work was to unveil the presence of 2,4-DNP in two ‘fat burners’ bought online, the 
Supplement 1 and the Supplement 2. 
Since many of these supplements have not yet been evaluated by the FDA it is possible 
that the ingredients that are included in package label do not correspond to the real 
content of the formulation. Thus, our second aim was to chemically characterize the 
products purchased and to compare their real composition with the labelled composition. 
A comparison among different capsules of the same product was also performed. 
The last objective was to elucidate the in vitro hepatotoxicity of these supplements and, 
in particular, of 2,4-DNP, which was deemed responsible for several intoxications 
associated with weight loss product users. In case of apparent citotoxicity, the 
mechanisms involved were elucidated. 
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PART 3 – CHEMICAL CHARACTERIZATION OF COMMERCIAL WEIGHT 
LOSS PRODUCTS 
 
CHAPTER 1: MATERIALS AND METHODS 
  
25 
3.1.1.  Reagents 
All the reagents used were of analytical grade. methanol and dichloromethane were 
obtained from Fisher Chemicals (Loures, Portugal). All other reagents were acquired 
from Sigma-Aldrich (Saint Louis, Missouri) unless stated otherwise. The purity of all 
standards is known and was always greater than 98.0% (w/w). 
 
3.1.2. ‘Fat Burners’ 
Two commercial formulations, Supplement 1 and Supplement 2, marketed for weight 
loss were purchased from Prozis website (www.prozis.com/pt), which offers a wide range 
of products related to supplementation and functional feeding mainly used for human 
consumption. Table 6 lists the characteristics of these products used for analyses. 
 
Table 6: Commercial formulations analysed in the study. 
 Formulation 
Expiration 
date 
Manufacturer 
Place of 
manufacturing 
Product form 
1 
Supplement 
1 
4th Feb, 
2018 
International 
Ingredients 
USA 
White capsules 
contained in a 
black plastic 
bottle 
2 
Supplement 
2 
Nov, 2018 
Universal 
Nutrition 
New 
Brunswick, 
New Jersey, 
USA 
Multicolour 
capsules 
contained in 
small plastic 
bags* sold in a 
metallic box 
* Each plastic bag contains 9 capsules: 2 white capsules + 1 red capsule + 2 blue capsules + 1 orange 
capsule + 1 yellow capsule + 1 red/white capsule + 1 blue/white capsule. Legend: USA – United States of 
America. 
 
Supplement 1 is considered a super-thermogenic product. The labelled composition was 
divided in three groups of ingredients, based on the claimed three benefits provided. 
Accordingly, Super-thermogenesis Complex includes Coleus forskohlii and L-theanine; 
Extreme Energy Complex includes caffeine anhydrous; and Powerfull Weight Loss 
Complex includes green coffee extract (C. canephora robusta). The label also indicates 
other ingredients, namely L-carnitine/ L-tartrate, cocoa extract (standardized for 6% 
theobromine), bioperine (black pepper 95% piperine), cayenne pepper (Capsicum 
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annuum), veggie complex (hypromellose, red iron oxide and titanium dioxide), vegetable 
cellulose, silicon dioxide and magnesium stearate. Recommended dosage by the 
manufacturer is one capsule for the first day; two capsules once daily for the second and 
third days; two capsules twice daily for the fourth day and beyond. In addition, the 
manufacturer recommends, for best results, using the product for 60 days, combined 
with diet and training. 
The Supplement 2 formula includes ingredients designed to stimulate metabolism, 
thermogenesis, diuresis, muscle preservation and thyroid function, as well as to provide 
extra energy and to suppress appetite. The eight different components described in the 
Supplement 2 label are: Stimulant/Thermogenic Complex that includes caffeine 
anhydrous, kola nut (seed), guarana seed, yerba mate (leaf) and raspberry extract; 
Metabolic Complex, which only includes polyphenols, such as green tea extract, oolong 
tea extract, black tea extract, coffee bean extract and white tea extract; Thyroid Complex 
that includes L-tyrosine, olive leaf extract (15% oleuropein) and Salvia officinalis (leaf); 
Water Shedding Complex that includes dandelion root (taraxol/taraxerol), nettle root, 
burdock, Arctium tappa root, buchu leaf, juniper berry fruit and celery seed; Nootropic 
Complex that includes gotu kola extract, choline bitartrate and bacopa monniera (leaf; 
bacopasides A & B); Cortisol Inhibiting Complex that includes ashwangandha extract 
(withanolides, panax ginseng – root, phosphatidylserine and magnolia bark extract), 
Cholecystokinin (CCK) Boosting Complex that includes Gymnema sylvestre leaves, 
apple pectin and jojoba seed extract (simmondsin); and Bioavailability Complex that 
includes ginger root (gingerols/shogaols), cayenne fruit, grapefruit (seed; 6,7-
dihydroxybergamottin), quercetin, citrus fruit extract (naragin) and Pepper nigrum seed 
extract. Recommended dosage by the manufacturer was two plastic bags (nine capsules 
each) a day, one pack on waking and the other one 4 to 6 hours later, in cycles of three 
weeks followed by interruption of one week. 
 
3.1.3.  Standards and samples preparation 
Three individual capsules of Supplement 1 and all capsules from three Supplement 2 
plastic bags were used. The husks were first removed and all the fine powders of each 
capsule were individually transferred into glass vessels and dissolved in methanol at a 
concentration of 1 mg/mL. The obtained suspensions were then sonicated for 15 
minutes. Two microliters of each solution were injected directly in the GC-MS equipment. 
Solutions of all standards (including, 2,4-DNP and caffeine) and the internal standard 
(IS) 4-hydroxy-3-methoxybenzylamine hydrochloride were also prepared at a 1 mg/mL 
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in and stored at -20ºC. All intermediate dilutions and working solutions were made up in 
methanol. 
 
3.1.4.  Derivatization and injection 
Solutions were analysed by GC-MS directly after the addition of 5 µL of 200 µg/mL IS to 
1 mL of samples and standards at 1 mg/mL. Alternatively, was also made an analysis of 
the samples and standards after derivatization with N-methyl-N-
(trimethylsilyl)trifluoroacetamide (MSTFA). In the latter case, derivatization was 
performed according to the method developed by Silva et al. (2010) with some 
modifications. Accordingly, 50 µL of 2,4-DNP standards and samples at 1 mg/mL were 
added of 5 µL of 200 µg/mL IS and 945 µL of methanol. Then, solutions were evaporated 
to dryness under nitrogen flow. Fifty microliters of dichloromethane and 50 µL of MSTFA 
were then added to the dried residue. Samples were vortex mixed and further incubated 
at 80°C for 30 min. After cooling to room temperature, 2 µL of sample were automatically 
injected into the GC-MS equipment. A summary of the procedures is shown in figure 9. 
 
 
 
Figure 9: Summary of sample preparation procedures for GC-MS analysis. Legend: GC-MS – 
Gas Chromatography coupled to Mass Spectrometry; IS – Internal Standard (4-hydroxy-3-
methoxybenzylamine hydrochloride); MSTFA – N-methyl-N-trimethylsilyl-trifluoroacetamide; N2 
– Nitrogen. 
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3.1.5.  GC-MS conditions 
GC-MS analysis was performed on a SCIONTM TQ (triple quadrupole) 436-GC-MS 
system (Bruker Daltonics, Fremont, CA) equipped with a SCION TQ mass detector and 
a Bruker Daltonics MS workstation software (version 8.2). A capillary column Rxi-5Sil 
MS (30 m × 0.25 mm × 0.25 μm) from RESTEK was used for the chromatographic 
separation. Helium C-60 (Gasin, Portugal) was used as the carrier gas at a constant flow 
rate of 1.0 mL/min. The injection was in split mode (1:10) and the injector temperature 
was 250°C (held for 20 min.). As for the oven temperature, it was held for 1 min at 80°C, 
followed by an increase at a rate of 20°C/min until reaching 250°C (held for 2 min) and 
finally an increase of 10°C/min to 300°C (held for 20 min). The MS detector was operated 
in electron ionization (EI) mode. Data acquisition was performed in full scan mode with 
a mass range between 50-500 m/z at a scan rate of 6 scan/s. 
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CHAPTER 2: RESULTS AND DISCUSSION 
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3.2.1. Research of 2,4-dinitrophenol (2,4-DNP) in weight loss commercial 
products 
As 2,4-DNP was categorised as a weight loss drug, a notorious growth in its demand 
was observed. Nevertheless, after the first fatalities, it was banned by FDA for human 
consumption. Despite its legal regulation and all reported toxic effects, 2,4-DNP-
containing products have still been commercialised, often sold under different names 
(Zaharia et al., 2016). These slimming products are not generally subjected to control by 
regulatory authorities and, as a consequence, they recurrently lack quantitative and/or 
qualitative standardization of the chemical content. Often, many substances that are not 
labelled on the package appear in the formulation, and the contrary also occurs, raising 
serious concerns regarding safety and marketing of these products. Furthermore, as 
many dietary supplements derive from plants, they are frequently considered as ‘natural’ 
products (Rocha et al., 2016), which transmits a false sense of safety to the consumers. 
Surveillance on this type of product is therefore of utmost relevance. So, we investigated 
the possibility of 2,4-DNP to be present as an adulterant in slimming supplements, even 
at very low detectable levels. 
We started this work by analysing and comparing the chromatographic profile and mass 
spectra of 2,4-DNP. Methanol was the solvent chosen for analysis. This choice was 
based on the fact that 2,4-DNP is a polar molecule that can be more easily extracted by 
polar solvents. The data obtained herein is shown in figure 10 and is line with the 2,4-
DNP data [retention time (RT) and mass to charge ratio (m/z)] already described in 
literature (Miranda et al., 2006; Robert and Hagardorn, 1983). Our data confirmed the 
characteristic mass spectra of 2,4-DNP with ion peaks of m/z 63, 53, 154, 184 and 91 
after fragmentation. 
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Due to the low volatility of 2,4-DNP, which could affect its chromatographic definition we 
also analysed the chromatographic profile and mass spectra of 2,4-DNP following 
derivatization with N-Methyl-N-(trimethylsilyl)trifluoroacetamide (MSTFA). Derivatization 
reactions are usually performed to increase volatility, decrease the polarity, and to make 
compounds more stable (Mahugo Santana et al., 2009). The introduction of a silyl group 
(R3Si) to a molecule (silylation) through derivatization with MSTFA is a process frequently 
used to enhance GC performance. The silylation involves the nucleophilic attack upon 
the silicon atom of the silyl donor, producing a bimolecular transition state. This 
mechanism involves the replacement of the active hydrogen on –OH, -SH, -NH, -NH2, -
COOH groups by a trimethylsilyl group, and occurs in molecules that display a good 
leaving group, which means molecules with low basicity, structure with ability to stabilize 
a negative charge in the transitional state, and low affinity between the leaving group 
and silicon atom. The reaction for silylation is show in the below equation (Orata, 2012; 
Sigma-Aldrich). 
𝑆𝑎𝑚𝑝𝑙𝑒 − 𝑂𝐻 + (𝐶𝐻3)3 − 𝑆𝑖 − 𝑋 →  𝑆𝑎𝑚𝑝𝑙𝑒 − 𝑂 − 𝑆𝑖 − (𝐶𝐻3)3  + 𝐻𝑋 
 
Figure 10: Full scan chromatographic profile (A) and mass spectra (B) of 2,4-
dinitrophenol (2,4-DNP) directly injected into the GC-MS after dissolution in 
methanol. 
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From the comparison of both methods, results obtained after derivatization of our 2,4-
DNP standards (figure 11) did not present greater sensitivity or increased resolution of 
the peaks, when compared with data from direct injections. Then, further analyses were 
performed with non-derivatized samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A survey was conducted regarding all products sold as ‘fat burners’ in websites dedicated 
to bodybuilding (for example, bodybuilding.com). It was notorious the diversity of 
products consumed with the purpose of body fat loss. Evidence indicated that in Portugal 
Prozis (prozis.com) is the most popular website to purchase such type of products. So, 
motivated by the variability of the products offered online, compared to that available in 
traditional stores, and by the information offered by these websites on the most 
commercialized and popular products, we decided to purchase online the two slimming 
products to be test in the current study. Supplement 1 and Supplement 2 formulations 
were selected and acquired through Prozis website. 
We further investigated the presence of 2,4-DNP in these two different commercial 
supplements with alleged thermogenic properties. For this, a comparison of 
Figure 11: Full scan chromatographic profile (A) and mass spectra (B) of 2,4-
dinitrophenol (2,4-DNP) injected into the GC-MS after dissolution in methanol 
and derivatization with N-methyl-N-(trimethylsilyl) trifluoroacetamide (MSTFA). 
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chromatograms, in terms of RT and mass spectra of 2,4-DNP chromatographic peak, 
between standards and samples was carried out. 
First, data from GC-MS analysis of methanol solutions of 2,4-DNP and Supplement 1 
were compared and revealed the absence of the drug, as no match between 2,4-DNP 
and Supplement 1 chromatographic profiles (RT and m/z) could be established (figure 
12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Similar results were obtained for Supplement 2, since 2,4-DNP was not detected in any 
of the capsules tested (figure 13). 
Figure 12: Chromatographic profiles of 2,4-dinitrophenol (2,4-DNP; brown) 
and Supplement 1 (green). 
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Rebiere et al. (2012) investigated the presence of several hazardous weight loss 
substances in adulterated slimming formulations. Although several illegal substances, 
which are regulated because of side effects or toxicological concerns, were detected, 
such as sildenafil, synephrine, clenbuterol, nicotinamide, phenolphthalein, rimonabant, 
sibutramine, N,N-didesmethylsibutramine, and yohimbine. All these substances are 
considered the most frequently found undeclared pharmacological ingredients in food 
supplements by FDA (Walker et al., 2016). On the contrary, and similar to our results, 
2,4-DNP was not found in the different dietary supplements analysed. In 2016, 2,4-DNP 
was also included in the List of undeclared and unauthorized pharmacological 
substances frequently reported in food supplements by the Rapid Alert System for Food 
and Feed (RASFF). 
In a study that investigated the characteristics of slimming products on the Brazilian 
clandestine market, Justa Neves and Caldas (2015) observed that sibutramine was the 
most referred substance in adulterated products whose declared origin was Brazil. This 
Figure 13: Chromatographic profiles of 2,4-dinitrophenol (2,4-DNP) and each of the 
capsules contained in a plastic bag of Supplement 2. 
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occurrence was similar to that published by Sadaka et al. (2011) concerning composition 
of weight loss products sold the Lebanese market. Sildenafil is also a very common 
substance in illicit dietary supplements, particularly in Italy (Damiano et al., 2014). 
 
3.2.2. Characterization of commercial products 
As we did not detect 2,4-DNP in the purchased products, we proceed to the investigation 
of the chemical profiles of the referred thermogenic formulations. The GC-MS method 
was again chosen to identify the various compounds present in this slimming formulation. 
Spectra of unidentified peaks observed in GC-MS data of Supplement 1 and Supplement 
2 samples were further searched through spectra databases supported by National 
Institute of Standards and Technology (NIST14). The identification process was based 
on EPA methods for determination of volatile/semi-volatile compounds, according to the 
respective RT, kovats indices and RMatch values (Milman, 2005). The methods used to 
characterize the weight loss dietary supplements are summarised in figure 14. 
 
 
 
The main difficult in the characterization and detection of adulterants in these products 
was that the matrices are often very different and compounds exhibit rather different 
physicochemical characteristics (Rebiere et al., 2012). The dissolution of compounds 
was also performed in methanol. This choice is in accordance with methodologies 
previously described in literature (Chen et al., 2009; Rocha et al., 2016; Vaysse et al., 
2010). Nevertheless, some problems of solubility had arisen due to elevated amount of 
Figure 14: Schematic representation of the procedure used for the chemical characterization of 
‘fat burners’. Legend: GC-MS – Gas Chromatography coupled to Mass Spectrometry; MSTFA – 
N-methyl-N-trimethylsilyl-trifluoroacetamide; NIST – National Institute of Standards and 
Technology. 
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plant extracts present in these formulations, but after testing alternative solvent systems, 
we considered that this would still be the most suitable solvent for this type of analysis. 
 
3.2.2.1. Supplement 1 
Supplement 1 was introduced in the market in 2002 as a weight loss supplement but 
shortly thereafter the first reports of acute hepatocellular injury appeared. The original 
formulation was then changed by the manufacturer but these types of intoxications 
continue to occur (Araujo and Worman, 2015; Garcia-Cortes et al., 2016). In 2009, FDA 
warned the public about the severe risk of liver injury attributed to the ‘fat burner’ and the 
manufacturer withdrew it (Avigan et al., 2016; Garcia-Cortes et al., 2016; Stickel and 
Shouval, 2015). Nowadays, Supplement 1 is marketed under a few different variants. 
Supplement 1 was listed as one of the most frequent products seized by Brazilian 
Federal Police, from 2007 to 2013 (da Justa Neves and Caldas, 2015). We choose 
another variant of these line of products – Supplement 1 (figure 15). 
 
 
 
 
 
 
 
 
 
In order to provide a more comprehensive characterization of the composition of the 
Supplement 1 Supplement 1, GC-MS analysis was carried out with and without 
derivatization. Accordingly, derivatization with MSTFA was performed due to its 
usefulness for the detection of early-eluting compounds. Derivatization allowed obtaining 
more clean chromatograms, better separations with increased resolution and response, 
Figure 15: Supplement 1 – Commercial product purchased from prozis.com to carry out this 
work. 
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and increased sensitivity of the method, as observed by chromatograms shown in figure 
16. 
 
 
Methanol solutions of three capsules of Supplement 1 were prepared, derivatized, and 
analysed in GC-MS with the aim of understanding if composition of different capsules of 
the same package are the same or if there is a lack of qualitative and quantitative 
uniformity, as described by other authors (Araujo et al., 2015). Similar chromatographic 
profiles were obtained for all of them (figure 17). 
Figure 16: Comparison between Supplement 1 chromatographic profile directly injected (A) into the 
GC-MS and injected after derivatization with N-methyl-N-trimethylsilyl-trifluoroacetamide (MSTFA) (B). 
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Using the mass spectrum information of each chromatographic peak (e.g., base peak 
and molecular ion) we could establish relationships with the spectra database. By 
performing the intersection of information obtained from mass spectra interpretation with 
mass spectra database (NIST14 library), we could identify the composition of this 
slimming product. In addition, the identity of lactic acid, oxoproline, tartaric acid, quininic 
acid, caffeine, palmitic acid and stearic acid was further confirmed. Based on knowledge 
of the molecular weight after derivatization and ions resulting from fragmentation, 
comparisons with retention times and the mass spectrum of the derivatized compounds 
and derivatized standards were established. Positive matches were obtained for all these 
seven compounds. The other compounds were assigned potential identifications through 
the analysis of their mass spectra and comparison with database (table 7). 
Figure 17: Full scan chromatographic profile of methanol solutions of Supplement 1 (HC) 
injected after derivatization with N-methyl-N-trimethylsilyl-trifluoroacetamide (MSTFA) of 
three different capsules (HC1, HC2 and HC3) of the same product, revealing qualitative 
similarity between them. More relevant peaks: 1 – Tartaric acid, 4TMS; 2 –  Unidentified 
peak; 3 – Caffeine; 4 – Palmitic acid, TMS; 5 – Stearic acid, TMS. 
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Table 7: Retention time (min), base peak (m/z), other characteristic ions (m/z), calculated kovats, library kovats, match and Rmatch values of active ingredients 
of Supplement 1 detected after derivatization with N-methyl-N-trimethylsilyl-trifluoroacetamide (MSTFA). 
Compound 
Retention 
time (min) 
Base peak 
(m/z) 
Characteristic 
ions (m/z) 
Calculated 
kovats 
Library 
Kovats 
Standard Match RMatch 
Lactic acid, 2TMS 3.51 73 147+117+75   × 915 960 
α-Hydroxyisobutyric acid, 2TMS 3.79 73 131+147+75 1089 1071  795 846 
L-5-Oxoproline, 2TMS 6.87 156 73+147+157   × 913 957 
1-Dodecanol, TMS 7.16 73 111+75+156 1567 1558  483 627 
L-(+)-Tartaric acid, 4TMS 7.49 73 147+292+74   × 866 913 
D-(-)-Fructofuranose (isomer 1) 8.43 117 73+217+437 1780 1792  553 614 
L-(-)-Sorbofuranose 8.50 73 217+147+75 1791 1779  846 857 
D-(-)-Fructopyranose, 5TMS 8.55 73 204+147+217 1800 1802  874 877 
Quininic acid, 5TMS 8.75 73 147+345+255   × 812 874 
Caffeine 8.87 194 67+109+55   × 949 949 
Palmitic acid, TMS 9.77 73 117+75+129   × 906 907 
1-Octadecanol, TMS 10.41 75 73+327+58 2148 2152  652 790 
Stearic acid, TMS 11.00 73 117+75+129   × 887 944 
11-Eicosenoic acid 11.89 57 83+55+75 2348 2360  464 552 
Arachidic acid, TMS 12.62 73 117+75+69 2436 2449  471 750 
Docosanol, TMS 13.50 75 73+383+57 2543 2542  692 774 
Behenic acid, TMS 14.23 117 73+69+95 2633 2644  608 742 
5-O-Feruloylquinic acid, 5TMS 17.74 73 75+345+249 3081 3074  712 786 
3-Caffeoylquinic acid 17.93 73 345+255+147 3102 3092  838 849 
4-O-Feruloylquinic acid, 5TMS 18.40 73 249+255+147 3149 3138  637 750 
Legend: m/z – mass to charge ratio; TMS – trimethylsilyl. 
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A total of 23 different compounds were detected. Most of them belongs to the class of 
sugars, specifically derivatives of fructose (fructofuranose, sorbofuranose and 
fructopyranose), as well as other substances such as are fatty acids (behenic acid, 
arachidic acid, eicosenoic acid, stearic acid and palmitic acid). Substances of other 
representative classes were also found, namely caffeine, which is a well-known 
stimulant. Other substances as caffeoylquinic acid and feruloyquinic acid are phenols, 
which present important antioxidant effects. Apparently, this composition is not 
associated with the possibility of toxic effects. Notwithstanding, it should be noted that 
Supplement 1 has already been reported as causing hepatotoxicity due to components 
such as Garcinia cambogia, Gymnema sylvestre, chromium polynicotinate, caffeine and 
green tea (Stickel and Shouval, 2015). 
In addition to the qualitative similarity exploited above, it was also noted that there are 
some differences between the Supplement 1 composition obtained by GC-MS analysis 
and that labeled on the package. This probably occurs due to the problems associated 
with low solubility of plant extracts in organic solvents but also due to unspecific 
information on the supplement label. In addition, we cannot conclude with certainty that 
a specific compound is not present in the product because it may be present at an 
insufficient amount to be detected under the conditions used in this study. 
 
3.2.2.2. Supplement 2 
Supplement 2 belongs to a set of products that includes hypertrophic supplement, 
anabolic supplement with essential amino-acids, non-hormonal anabolic supplement, 
pre-workout muscle volumizing supplement, joint support supplement, essential fatty 
acids supplement, rest and recovery supplement and multivitamin supplement. Along 
with Supplement 1, Supplement 2 was also listed as one of the most frequent products 
seized by Brazilian Federal Police, from 2007 to 2013 (da Justa Neves and Caldas, 
2015). Supplement 2 is a thermogenic formulation that was selected among all varieties 
to the present study (figures 18). The package label of the product presenting chemical 
composition is displayed in figure 19. 
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Similar to the procedure performed for Supplement 1, nine capsules of Supplement 2 
(1–9) contained in each of the three plastic bags (A, B, and C) were dissolved in methanol 
and directly injected into the GC-MS equipment. In parallel derivatization with MSTFA of 
these samples was also performed. The obtained chromatograms are shown in figure 
20. 
 
Figure 19: Label of Supplement 2. It is clear on the package label the indication ‘these 
statements have not been evaluated by the FDA’.  
Figure 18: Supplement 2. Commercial product purchased from prozis.com to carry out this 
work. The capsules were wrapped with plastic bags, which by turn were sold in a metallic 
container. 
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According to the chromatograms presented, we verify that the derivatization process 
increased the sensitivity of the GC-MS method and also allowed more clean 
chromatograms. 
Methanol solutions of Supplement 2 capsules (1–9) contained in three different plastic 
bags (A – C: composed of nine capsules each) were prepared, derivatized, and analysed 
in GC-MS with the aim of understanding if composition of different capsules of the same 
package would be the same or lack qualitative and quantitative uniformity. 
Results of capsules presenting the same colour from each of the three different plastic 
packages (A – C), produced similar chromatographic profiles, as exemplified for capsule 
1, in figure 21. Similarly, chromatograms of capsules 2–9 revealed homogeneity in 
qualitative composition among the different plastic packages. 
 
 
 
 
 
Figure 20: Comparison between Supplement 2 chromatograms obtained without (A) or with (B) 
derivatization with N-methyl-N-trimethylsilyl-trifluoroacetamide (MSTFA). 
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Using the mass spectrum information of each chromatographic peak (e.g., base peak 
and molecular ion) we could establish relationships between experimental data and the 
spectra database. The presence of lactic acid, threonine, quininic acid, caffeine, palmitic 
acid, stearic acid and catechin were confirmed by comparing retention times and mass 
spectra of each chromatographic peak with the respective standards. Positive matches 
were obtained for all these seven compounds. The other substances were assigned 
potential identifications through the analysis of their mass spectra and comparison with 
compounds of database (NIST14 library) (Table 8). 
 
 
Figure 21: Full scan chromatograms of methanol solutions of capsule 1 (white capsule) 
from plastic bags A, B and C of Supplement 2, injected after derivatization with N-
methyl-N-trimethylsilyl-trifluoroacetamide (MSTFA), revealing similar qualitative 
composition. More relevant peaks: 1 – Unidentified peak; 2 – Unidentified peak; 3 – 
D-(-)-Tagatofuranose; 4 – Quininic acid, 5TMS; 5 – Caffeine; 6 – Unidentified peak; 7 
– Palmitic acid, TMS; 8 – Stearic acid, TMS; 9 – Unidentified peak; 10 – Lactulose; 11 
– Unidentified peak; 12 – Catechine, 5TMS; 13 - Epigallocatechin, 6TMS. 
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Table 8: Retention time (min), base peak (m/z), other characteristic ions (m/z), calculated kovats, library kovats, match and Rmatch values of active ingredients 
of Supplement 2 detected after derivatization with N-methyl-N-trimethylsilyl-trifluoroacetamide (MSTFA). 
Compound 
Retention 
time (min) 
Base peak 
(m/z) 
Characteristic 
ions (m/z) 
Calculated 
kovats 
Library 
Kovats 
Standard Match RMatch 
Lactic acid, 2TMS 3.50 73 147+117+130   × 771 907 
L-Threonine 4.10 73 77+116+134   × 437 439 
D-(-)-Tagatofuranose 8.49 73 217+147+75 1791 1801  905 908 
D-(+)-Talofuranose 8.69 73 217+75+129 1829 1823  718 755 
Quininic acid, 5TMS 8.76 73 147+345+75   × 801 861 
D-(+)-Galactopyranose, 5TMS 8.93 73 204+191+147 1877 1889  856 870 
Caffeine 9.06 194 67+109+55   × 756 864 
2,3,4,5,6-pentahydroxyhexanoic 
acid, 4TMS 
9.42 73 217+147+129 1972 1981  553 651 
Palmitic acid, TMS 9.78 73 117+75+129   × 829 851 
Stearic acid, TMS 11.01 73 117+75+129   × 814 908 
2-Palmitoylglycerol, 2TMS 13.50 73 129+75+147 2543 2558  659 711 
Lactulose 13.72 73 217+75+147 2569 2587  764 779 
Catechine, 5TMS 15.86 73 368+355+369   × 808 859 
Epigallocatechin, 6TMS 16.39 73 456+355+457 2914 2904  852 860 
Legend: m/z – mass to charge ratio; TMS – trimethylsilyl.
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Similarly to Supplement 1, analysis of Supplement 2 revealed high predominance of 
sugars and fatty acids. A total of 14 different substances were identified; among them, 
the sugars tagatofuranose, talofuranose, galactopyranose, lactulose and gulonic acid. 
Fatty acids palmitic acid and stearic acid were also present in all capsules (1–9), along 
with other substances such as the antioxidant polyphenols catechin and 
epigallocatechin. Apparently, this composition is not related to the possibility of toxic 
effects. 
We detected the presence of amino acids in some capsules such as, threonine in 
capsule 1, proline in capsule 3, tyrosine in capsule 4, alanine in capsule 6 and valine, 
isoleucine, proline and threonine in capsule 9. Also, in capsule 5 linoleic acid and other 
two fatty acids were noticed. According to Williams (2005), amino acids are involved in 
the secretion of anabolic hormones, preventing adverse effects of overtraining and 
preventing mental fatigue. 
The lack of consistency in qualitative composition is a serious threat for users and 
increases the risk of acute toxicity associated with the product consumption. This 
inconsistency also hampers the assessment of the clinical state of the patient and 
consequently the application of an appropriate treatment. The supplements that are 
adulterated may contain only one or more unauthorized substances as described by 
Vaysse et al. (2010). When a substance is replaced by another on the product label, 
when it is omitted, or when the amount presented and labeled diverge, the effects can 
be significantly different. These differences will have an impact on duration of action, on 
the time required to cause the effects, and on the multiplicity of effects and respective 
interactions, and could result in severe intoxications. In addition, all these problems 
demonstrate the lack of control associated to these products regarded as ‘safe’, showing 
that sellers only concern monetary profits, putting aside the health of users. Worryingly, 
recent studies on herbal and dietary supplements indicate that herbal-related drug-
induced liver injury have increased between 2004 to 2013 (Navarro et al., 2014). As 
example, another product used for weight loss and improvement of physical 
performance, was associated to liver pathology (acute and fulminant hepatitis) (Johnston 
et al., 2016; Stickel and Shouval, 2015). 
 
3.2.3. Caffeine quantitation 
Caffeine is frequently present in dietary supplements as a stimulant. According to a study 
published by Rebiere et al. (2012), the amount of caffeine per capsule of dietary 
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supplements ranged between 4 mg and 327 mg (per unit). Of concern, even ingredients 
such caffeine, which is legal and common in supplements, can provoke serious toxicity 
(da Justa Neves and Caldas, 2015), as supported by case reports of caffeine 
intoxications (Holmgren et al., 2004). So, we decided to quantify the amount of caffeine 
present in these two different formulations. 
By virtue of the lacking of binding sites for MSTFA, the molecular structure of caffeine, 
and consequently the originated mass spectrum, is not altered with derivatization. 
Methanol solutions with different caffeine concentrations were directly injected into the 
GC-MS and a standard curve calibration was plotted, allowing us to quantify the amount 
of caffeine present in capsules that proved to contain caffeine in their composition in 
previous analyses. We verified that Supplement 1 has approx. 45 mg of caffeine per 
capsule. So, assuming the manufacturer’s recommendations of a daily intake of two 
capsules, consumers will ingest an amount of approx. 90 mg of caffeine per day. For the 
sake of comparison, a cup of coffee contains about 100 mg of caffeine (Holmgren et al., 
2004) or between 40–150 mg, depending on the source (Kerrigan and Lindsey, 2005). 
Since the amount we achieved in our experimental determination is close to that present 
in a cup of coffee, it seems quite acceptable, considering that the maximum 
recommended daily intake is approximately 400 mg (equivalent to the administration of 
four coffee cups). 
Regarding the Supplement 2, only two of the capsules of each plastic bag contained 
caffeine in their composition, namely capsules 1 and 2. Nevertheless, we obtained the 
values of 130 mg and 294 mg for quantification of caffeine in these two capsules. 
Considering that the manufacturer instructions suggest a daily intake of two plastic 
sachets, the amount of caffeine ingested is about 848 mg of caffeine per day. This value 
significantly exceeds the recommended daily intake and the dosages commonly 
observed in numerous dietary supplements, which range from 32 to 200 mg (Kerrigan 
and Lindsey, 2005). Nevertheless, some studies point out to the discrepancies observed 
in the real amounts of caffeine present in supplements and the significantly different 
amounts claimed on the respective labels (Inacio et al., 2016). 
Although caffeine intoxications are not very frequent, it has some characteristics that 
makes it riskier than usually considered. It is easy to obtain, has fast effect and some 
interactions with pharmaceuticals, such as antidepressants, that substantially raise the 
plasma level of caffeine after simultaneous intake (Holmgren et al., 2004).  
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PART 4 – HEPATOTOXICITY OF 2,4-DINITROPHENOL (2,4-DNP) 
 
CHAPTER 1: MATERIALS AND METHODS 
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4.1.1.  Reagents 
As referred, the Supplement 1 and Supplement ‘fat burners’ were purchased from Prozis 
Portugal. Unless stated otherwise, all other chemicals were purchased from Sigma-
Aldrich (Lisbon, Portugal) and all the cell culture reagents from Gibco (Alfagene, Lisbon, 
Portugal). 
 
4.1.2.  Animals 
Male Wistar Han rats with a body weight of 150–250 g were purchased from Charles 
River Laboratories (Barcelona, Spain) and used in all experiments as the source of 
hepatocytes. Upon arrival at the Rodent Animal House Facility of our institution, the 
animals were acclimated in polyethylene cages with wire-mesh at the top, lined with 
wood shavings, for at least 2 weeks prior to use. The animals were kept under an aseptic 
environment with controlled temperature (20 ± 2°C), humidity (40-60 %) and lighting (12h 
light/dark cycle) conditions, and had ad libitum access to sterile water and standard rat 
chow. Surgical procedures for the isolation of hepatocytes were always conducted 
between 8 and 10 a.m. and were performed after animal anaesthesia induced by an 
intraperitoneal injection of a combination of 20 mg/kg xylazine (Rompun® 2%, Bayer 
HealthCare, Germany) and 100 mg/kg ketamine (Clorketam® 1000, Vétoquinol, France) 
and maintained by inhalation of isoflurane (IsoVet® 1000, B. Braun VetCare, Germany). 
Housing and experimental treatment of animals were approved by the local committee 
for the welfare of experimental animals and performed in accordance with national 
legislation by investigators accredited for laboratory animal use by the national authority 
Direção Geral de Alimentação e Veterinária (DGAV), under the terms of the Law No. 
113/2013, of 7th August (Decreto-Lei N.º 113/2013, de 7 de Agosto, in Diário da 
República, 1.ª série – N.º 151). 
 
4.1.3. Isolation and culture of primary hepatocytes 
The technique used for the isolation of rat hepatocytes is based on a collagenase 
perfusion method, as described by Dias da Silva et al. (Dias da Silva et al., 2017). 
Following a V-shaped incision of the abdomen, the exposed portal vein was punctured 
with a cannula and the liver perfused in situ with a sterile ethylene glycol-bis(2-
aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA)-buffer at 37°C, for approximately 15 
min, at an output flow of 10 mL/min, to allow the cleavage of the hepatic desmosomes 
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through calcium sequestration by EGTA. The EGTA-buffer was prepared with 248 mL of 
9 g/L d-glucose, 40 mL of Krebs-Henseleit buffer (60 g/L NaCl, 1.75 g/L KCl, and 1.6 g/L 
KH2PO4; pH 7.4), 40 mL of 60 g/L 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES) (pH 8,5), 30 mL of minimum essential media (MEM) non-essential amino acid 
solution (100), 30 mL of MEM amino acids solution (10), 4 mL of 7 g/L l-glutamine, 
and 1.6 mL of 47.5 g/L EGTA (pH 7.6). Subsequently, hepatic collagen was hydrolysed 
by perfusion of the liver with a sterile collagenase solution for 10-15 min, at 37°C; this 
consisted of 155 mL of 9 g/L d-glucose, 25 mL Krebs-Henseleit buffer; 25 mL of 60 g/L 
HEPES (pH 8.5), 15 mL of MEM non-essential amino acid solution (100); 15 mL of 
MEM amino acids solution (10); 10 mL of 19 g/L CaCl2.2H2O solution, 2.5 mL of 7 g/L 
l-glutamine solution, and 300 U/mL collagenase type IA from Clostridium histolyticum. 
During the two-step perfusion, both solutions were continuously aerated by a stream of 
carbogen (95% O2 and 5% CO2). After perfusion, the liver was dissected, removed from 
the animal and the hepatocytes were dissociated in a sterile suspension buffer by 
disruption of the Glisson's capsule. The suspension buffer contained 124 mL of 9 g/L d-
glucose, 20 mL Krebs-Henseleit buffer, 20 mL of 60 g/L HEPES buffer (pH 7.6), 15 mL 
of MEM non-essential amino acid solution (100), 15 mL of MEM amino acids (10), 2 
mL of 7 g/L l-glutamine solution, 1.6 mL of 19 g/L CaCl2.2H2O solution, 0.8 mL of 24.6 
g/L MgSO4.7H2O solution, and 400 mg bovine serum albumin. As the viable hepatocytes 
have a higher density than the non-parenchymal cells and dead hepatocytes, the 
suspension was purified through three cycles of low-speed centrifugation (250 × g, for 5 
min, at 4°C) to obtain a highly enriched suspension of hepatocytes. The initial viability of 
isolated hepatocytes was estimated by the trypan blue exclusion test and it was always 
above 85%. Trypan blue is an organic negatively charged dye, which is only included 
inside the cells that present membrane cytoplasmic damage, as a result of the loss of 
energy-dependent transport and, consequently, of the selectivity in the compounds that 
traverses the membrane (Strober, 2001). 
A suspension of 5 × 105 viable cells/mL in complete culture medium [William’s E medium 
(Sigma-Aldrich, Lisbon, Portugal) supplemented with 10% fetal bovine serum (FBS), 2 
ng/mL insulin solution from bovine pancreas (Sigma-Aldrich, Lisbon, Portugal), 5 nM 
dexamethasone (Sigma-Aldrich, Lisbon, Portugal), 1% antibiotic solution (10.000 U/mL 
penicillin and 10.000 µg/mL streptomycin), 10 µg/mL gentamicin and 0,25 µg/mL 
amphotericin B] was seeded onto the central 60 wells of 96-well plates (5 × 104 cells/well) 
or onto 6-well plates (1 × 106 cells/well), pre-coated with collagen. After seeding, primary 
hepatocytes were incubated overnight at 37°C, in an atmosphere of 5% CO2, to allow 
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cell adhesion. After adhesion, the medium was gently aspirated and the cells were 
exposed to the test compounds at the selected concentrations. 
 
4.1.4. Incubation of primary rat hepatocytes with test compounds 
All drug stock solutions were prepared and stored at -20°C. Subsequent test dilutions 
were freshly prepared in exposure medium (complete cell culture medium without FBS), 
immediately before each experiment. 
Stock solutions of 2,4-DNP were prepared in ethanol (PanReac AppliChem, analysis 
99,8%; Germany). For the cell viability experiments [neutral red (NR), 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and lactate dehydrogenase 
(LDH) assays], primary rat hepatocytes were exposed to a large interval of 2,4-DNP 
concentrations (ranging from 0.55 µM to 10 mM). All the other assays that allowed to 
clarify the mechanisms of hepatotoxicity were performed at five test concentrations: 1 
µM; 10 µM; 50 µM; 100 µM; and 200 µM.  
Stock solutions of Supplement 1 and Supplement 2 ‘fat burners’ were prepared by 
extracting the content of each capsule with 20 mL Hank’s Balanced Salt Solution 
(HBSS). These extracts were sonicated for 15 min and the obtained solution was filtered. 
These solutions were then used for the in vitro evaluation of cytotoxicity. One aliquot (1 
mL) of each extract was evaporated under nitrogen flow. The obtained residue was 
resuspended in methanol and characterized by GC-MS. For the evaluation of the elicited 
mortality by the MTT reduction assay, the cells were exposed to concentrations ranging 
from 228 ng/mL to 100 µg/mL. 
All compound incubations were performed for 24h, at 37°C, in a humidified 5% CO2 
atmosphere. 
 
4.1.5. Cytotoxicity by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) reduction assay  
The cytotoxic effects of 2,4-DNP and of the fat burner extracts were determined using 
the MTT reduction assay. This assay measures the succinate dehydrogenase activity, 
an indicator of metabolically active mitochondria. The MTT, a soluble yellow dye, is 
reduced to insoluble purple formazan crystals by these mitochondrial reductases. This 
reaction only occurs in living cells, providing a measure of cell viability that can be 
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spectrophotometrically quantified. A protocol previously described by Dias da Silva et al. 
(2014) was used. Briefly, after 24h incubations with the test compounds, the culture 
medium was aspirated. Then, 100 µL of a fresh solution of 1 mg/mL MTT prepared in 
cell culture medium was gently added to the attached cells. Plates were incubated at 
37°C for 30 min in a humidified, 5% CO2 atmosphere. After this, the MTT solution was 
removed and the formed intracellular crystals of formazan were dissolved in 100 µL of 
dimethyl sulfoxide (DMSO). The absorbance was measured at 550 nm, after 15 min 
shaking, in a multi-well plate reader BioTek Synergy™ HT (BioTek Instruments, Inc.). 
Because MTT is a photosensitive dye, all steps of the procedure were done under light 
protection. 
Data were obtained from four independent experiments for 2,4-DNP or from one 
independent experiment for ‘fat burner’ extracts, run in triplicates, with each plate 
containing increasing concentrations of the test compounds. To reduce inter-
experimental variability, data from each plate were normalized and scaled between 0% 
(negative controls, cells treated only with cell exposure medium) and 100% of the effect 
(positive controls, cell exposure medium with 1% Triton X-100) and results from four 
independent experiments were graphically presented as percentage of decrease in MTT 
reduction versus 2,4-DNP concentration (mM). 
 
4.1.6. Cytoplasmic membrane integrity by the lactate dehydrogenase (LDH) 
leakage assay 
The LDH leakage assay was performed to access the cytoplasmic membrane integrity 
of primary rat hepatocytes after exposure to 2,4-DNP. This is one of the most widely 
used assays for the determination of the toxicity of drugs in vitro. Since LDH is a 
cytoplasmic oxidoreductase, its presence in the extracellular medium is indicative of 
alterations in membrane permeability and consequently in cell integrity. Therefore, the 
assay offers a feasible indication of cell viability. The enzyme LDH catalyses the 
reversible conversion of pyruvate to lactate in the presence of β-nicotinamide adenine 
dinucleotide (β-NADH), which in turn is oxidized to nicotinamide adenine dinucleotide 
(NAD+). 
At the end of the incubation period with the cell treatments, a 10 µL aliquot of cell 
exposure medium of each well was placed into a new 96-well plate. Then, 40 µL of 0.05 
M potassium phosphate buffer (pH 7.4; KH2PO4; Merck) and 200 µL of 0.15 mg/mL β-
nicotinamide adenine dinucleotide (β-NADH) solution were added. Immediately before 
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the absorbance reading, 25 µL of 2.5 mg/mL sodium pyruvate solution were added into 
each well to start the reaction. Both β-NADH and sodium pyruvate solutions were freshly 
prepared in potassium phosphate buffer. The kinetic of the oxidation of NADH to NAD+ 
was followed by measuring the absorbance at 340 nm, every 16 seconds, for 3 min, 
using an automatic plate reader Power Wave X™ (BioTek Instruments, Inc.), in a kinetic 
photometric mode. The data obtained in four independent experiments were scaled 
between positive (culture media with 1% Triton X-100; 100% cell death) and negative 
(cells treated only with cell culture medium; 0% cell death) controls and results were 
graphically presented as percentage of extracellular LDH versus 2,4-DNP concentration 
(mM). 
 
4.1.7. Lysosome integrity by the neutral red (NR) incorporation assay 
To provide supplementary cell viability data, we performed the NR uptake assay. This 
assay provides an indirect quantitative estimation of the number of viable cells in culture 
through the evaluation of the lysosomal integrity. It is based on the ability of live cells to 
incorporate and bind the weak cationic dye NR, which crosses the cell membrane by 
non-ionic diffusion, and accumulates in the lysosome of viable cells by interaction with 
anionic sites in the lysosomal matrix. Dead or damage cells lose their ability to retain the 
dye and, consequently, lose their colour in the washing procedure. 
At the end of 24h of incubation with 2,4-DNP, the exposure medium of the primary rat 
hepatocytes was aspirated and added 100 µL of 50 µg/mL NR solution, prepared in 
culture medium. The cells were incubated at 37°C in a humidified, 5% CO2 atmosphere 
for 30 min, allowing the lysosomes of viable cells to incorporate the dye. Then, the cells 
were carefully washed twice with 200 µL HBSS to eliminate extracellular dye (that was 
not incorporated in dead or damaged cells) and lysed with 100 µL of lysis solution (50% 
ethanol, 1% glacial acetic acid, 49% water solution). The absorbance was measured at 
540 nm in a multi-well plate reader BioTek Synergy™ HT (BioTek Instruments, Inc.). The 
data obtained in four independent experiments were normalised to positive (1% Triton 
X-100) and negative (only culture medium) controls and results were graphically 
presented as percentage of cell death versus 2,4-DNP concentration (mM). 
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4.1.8. Measurement of intracellular reactive oxygen (ROS) and nitrogen (RNS) 
species 
The intracellular reactive oxygen (ROS) and nitrogen (RNS) species production was 
monitored via 2’,7’-dichlorodihydrofluorescein diacetate (DCFH-DA) fluorescence assay, 
as described by Dias da Silva et al. (2014). DCFH-DA is a lipophilic sensitive probe that 
readily diffuses into the cells, where it is deacetylated by cellular esterases, producing 
2’,7’-dichlorodihydrofluorescein (DCFH). Then, DCFH is further oxidized by intracellular 
ROS and RNS, generating the green fluorescent 2’,7’-dichlorofluorescein (DCF), which 
is polar and trapped within the cells. 
As DCFH-DA is a non-water-soluble powder, a 4 mM DCFH-DA stock solution was 
initially prepared in DMSO and stored at -20°C in an opaque airtight container. 
Immediately before each experiment, the final concentration was made up in fresh cell 
culture medium (ensuring that the final concentration of DMSO did not exceed 0.05%). 
On the day of the experiment, hepatocytes in 96-well plates were incubated with 10 µM 
DCFH-DA, for 30-60 min, at 37°C, previous to the hepatocyte incubations with 2,4-DNP. 
The cells were then rinsed with HBSS and incubated, at 37°C, during 24h, with the 2,4-
DNP test concentrations. A blank control (no cells) was also included in the plate. 
Fluorescence was measured in a multi-well plate reader BioTek Synergy™ HT (BioTek 
Instruments, Inc.) set to 485 nm excitation and 530 nm emission. As DCFH-DA is 
photosensitive, all steps of the procedure were performed under light protection. The 
data from four independent experiments are presented as the percentage of negative 
controls, with each concentration tested in three replicates within each experiment. 
 
4.1.9. Measurement of intracellular total glutathione (tGSH) and oxidized 
glutathione (GSSG) 
Total glutathione (tGSH) and oxidized glutathione (GSSG) levels were determined by the 
5,5'-dithiobis[2-nitrobenzoic acid] (DTNB)-GSSG reductase-recycling assay, as 
previously described by Dias da Silva et al. (2014). For this purpose, primary rat 
hepatocytes were seeded in 6-well plates and exposed to 2,4-DNP, at 37°C. After a 24h-
incubation period, cells were rinsed with 1 mL HBSS, scrapped with 300 µL 5% perchloric 
acid (HClO4, w/v; Merck) per well, and incubated for 20 min, at 4°C. After centrifugation 
(13,000g, 5 min, 4°C), the supernatants were collected and stored at -20°C until further 
determination of GSH and GSSG. The obtained pellet was suspended in NaOH 1 M and 
used for protein quantification, through the Lowry assay. For tGSH determination, the 
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supernatants of samples, blank (5% HClO4) and standards were neutralized with 200 µL 
0.76 M KHCO3 (vortex mixing until there was no formation of CO2), on ice. The samples 
were then centrifuged for 10 min, at 13,000g, at 4°C, and 100 µL of each supernatant 
were added to a 96-well plate followed by 65 µL of a freshly prepared reagent solution 
containing 4 mM DTNB and 0.69 mM NADPH in a phosphate buffer (71.5 mM Na2HPO4; 
71.5 mM NaH2PO4.H2O; 0.63 mM EDTA; pH 7.5). Samples were incubated for 15 min at 
30°C. Then, 40 µL of 10 U/mL glutathione reductase (GR) solution (freshly prepared in 
phosphate buffer) was rapidly added to all samples. The consequent formation of 5-thio-
2-nitrobenzoic (TNB) by oxidation of GSH was followed for 3 min, every 10 seconds, at 
405 nm, using a multi-well plate reader (Power Wave XTM, BioTek Instruments, Inc.) 
and compared with a GSH standard curve prepared in 5% HClO4. To determine 
intracellular GSSG, 10 µL of 2-vinylpyridine were added to 200 µL of neutralised 
supernatants (samples, blank and standards) and mixed for 1h, at 4°C. As 2-vinylpyridine 
blocks GSH, GSSG will be determined as described for tGSH. The amount of reduced 
glutathione (redGSH) was calculated by subtracting GSSG from the tGSH [redGSH = 
tGSH – (2 × GSSG)]. The GSSG standard solutions were prepared in 5% HClO4. The 
standard concentrations ranged between 0.25 µM and 15 µM for GSH and between 0.10 
µM and 13 µM for GSSG. Results from four independent experiments were normalised 
to the protein content and the final results were presented as nmol per mg of protein. 
 
4.1.10. Assessment of mitochondrial membrane potential (ΔΨm) 
Assessment of mitochondrial integrity was performed by measuring 
tetramethylrhodamine ethyl ester (TMRE) inclusion as described by Dias da Silva et al. 
(2014). TMRE is a cell permeable fluorescent dye, positively charged, that labels active 
mitochondria by accumulation as a consequence of to their relative negative charge. 
Primary rat hepatocytes were seeded onto 96-well plates and incubated with 2,4-DNP 
for 24h, at 37°C. At the end of the incubation period, the cells were rinsed with HBSS 
and incubated at 37°C, for 15-30 min, with 100 µL of 2 µM TMRE, in the dark. A 2 mM 
TMRE stock solution was initially prepared in DMSO (TMRE is a non-water-soluble 
powder) and stored at -20°C, protected from light. This final 2 µM concentration of TMRE 
was prepared in fresh culture media, shortly before use (ensuring that the final 
concentration of DMSO did not exceed 0.05%). Then, the media was gently aspirated 
and the cells were washed with 200 µL HBSS. Fluorescence was measured on a 
fluorescence multi-well plate reader (BioTek Synergy™ HT, BioTek Instruments Inc.) set 
to 544 nm excitation and 590 nm emission. As TMRE is photosensitive, all steps of the 
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procedure were performed under light protection. The data obtained in four independent 
experiments with each concentration tested in three replicates were calculated as the 
percentage of negative controls. 
 
4.1.11. Measurement of intracellular adenosine triphosphate (ATP) 
The ATP levels were quantified by a bioluminescence assay that measures the light 
formed in the oxidation of luciferin, catalysed by luciferase in the presence of ATP, as 
described by Dias da Silva et al. (2015). Primary rat hepatocytes were seeded in 6-well 
plates and exposed to 2,4-DNP, at 37°C. After a 24h-incubation period, cells of each well 
were rinsed with 1 mL HBSS and scrapped with 300 µL 5% perchloric acid (w/v). 
Samples were incubated for 20 min, at 4°C. After centrifugation (13,000 g, 5 min, 4°C), 
the obtained pellet was suspended in 1 M NaOH and used for protein quantification, 
through the Lowry assay. The supernatants were collected and kept at -20°C until further 
ATP determination. The thawed acidic supernatants were then neutralized with an equal 
volume of 0.76 M KHCO3 and centrifuged for 10 min, at 13,000g (4°C) and the ATP 
contents were measured in triplicate by adding 75 µL of the neutralized supernatants, 
standards or blank (5% HClO4, w/v) to 75 µL of the D-luciferin-luciferase solution [0.15 
mM luciferin; 300,000 light units of luciferase from Photinus pyralis (American firefly); 50 
mM glycine; 10 mM MgSO4; 1 mM Tris; 0.55 mM EDTA; 1% BSA (pH 7.6)]. ATP 
calibration curve was obtained with standard stock solutions of ATP prepared in 5% 
HClO4. The emitted light intensity of the samples was determined using a luminescence 
multi-well plate reader (BioTek Synergy™ HT, BioTek Instruments Inc.) and compared 
with an ATP standard curve (1.25–20 µM) performed within each experiment. Data from 
four independent experiments were normalized to the protein content and the results 
were expressed as nmol per mg of protein. 
 
4.1.12. Determination of protein 
The protein content in the samples for ATP and GSH/GSSG determinations was 
quantified by the Lowry assay (Lowry et al., 1951). Accordingly, 50 µL of each 
supernatant, standard or blank were transferred in triplicate into a 96-well plate and 
added with 100 µL reagent A (14.7 mL of 2% Na2CO3; 150 µL of 2% KNaC4H4O6.4H2O 
and 150 µL of 1% CuSO4.5H2O), extemporaneously prepared. The plate was incubated 
for 10 min at room temperature. Then, 150 µL of 15× diluted Folin and Ciocalteu’s phenol 
reagent (Merck Millipore) were added into each well. The plate was again incubated for 
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10 min at room temperature and the absorbance was measured at 750 nm in a 96-well 
microplate reader Power Wave XTM (BioTek Instruments, Inc.). Protein bovine serum 
albumine (BSA) standards (31.25–1000 µg/mL) were prepared in 1M NaOH. 
 
4.1.13. Measurement of caspase-3, caspase-8, caspase-9 activities 
Primary rat hepatocytes seeded onto 6 well-plates were incubated with 2,4-DNP for 24h, 
at 37°C (two wells were used per each treatment condition). After this period, the cell 
treatment medium was removed. The cells were washed twice and added of 75 µL of 
complete lysis buffer [50 mM HEPES; 0.1 mM EDTA; 0.1% 3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS); supplemented with 1 
mM dithiothreitol (DTT); pH 7.4]. Following incubation at 4°C, for 30 min, cells were 
scrapped and collected into 2 mL centrifuge tubes. After vortex-mixed and incubated, 
samples were centrifuged at 13,000g, for 10 min, at 4°C. Fifty µL of the supernatant 
(which contains the cytoplasmic fraction) were placed into a 96-well plate and added of 
200 µL of complete assay buffer (100 mM NaCl; 50 mM HEPES; 1 mM EDTA; 0.1% 
CHAPS; 10% glycerol; supplemented with 10 mM DTT; pH 7.4). This assay was based 
on the hydrolysis of the peptide substrates specific for each caspase. The reaction was 
started by adding 5 µL of caspase-3 peptide substrate Acetyl-Asp-Glu-Val-Asp-p-
Nitroanilide (Ac-DEVD-pNA, stock concentration 4 mM), caspase-8 peptide substrate 
Acetyl-Ile-Glu-Thr-Asp-p-Nitroaniline (Ac-IETD-pNA, stock concentration 10 mM) or 
caspase-9 peptide substrate Acetyl-Leu-Glu-His-Asp-p-Nitroanalide (Ac-LEHD-pNA, 
stock concentration 10 µM) per well and incubating for 24h, at 37°C, protected from light. 
The caspase-induced release of the p-nitroanilide moiety of the substrates presents high 
absorbance at 405 nm, as determined in a multi-well plate reader BioTek Synergy™ HT 
(BioTek Instruments, Inc.) (Dias-da-Silva et al., 2015). The absorbance of blanks (non-
enzymatic control) was subtracted from each value of absorbance and the data were 
normalized to the amount of protein of each sample. The protein content in the 
cytoplasmic fraction was measured using the Bio-Rad DC protein kit as described by the 
manufacturer, and BSA solutions were used as standards (31.25–1000 µg/mL). Results 
from four independent experiments were expressed as percentage of negative controls. 
 
4.1.14. Statistical analysis 
The normalized MTT, LDH and NR assays data from four were fitted to the dosimetric 
Logit model, which was chosen based on a statistical goodness-of-fit principle: γ = θmax 
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/ {1 + exp [- θ1 - θ2 × log(x)]}, where θmax is the maximal observed effects, θ1 is the 
parameter for location, θ2 is the slope parameter and x is the concentration of test 
compound. To compare concentration-response curves, the extra sum-of-squares F test 
was used. Results from ROS/RNS, GSH/GSSG, ΔΨm and ATP assays are presented 
as mean ± standard error of the mean (SEM) from four independent experiments. 
Normality of the data distribution was assessed by three methods, the Kolmogorov-
Smirnov, D’Agostino & Pearson, and Shapiro-Wilk normality tests. Statistical 
comparisons between groups were performed by the test that better suited the data set 
of each assay (see legends of the graph figures), as indicated by the GraphPad Prism 
software version 7.0 (GraphPad software, San Diego, CA, USA) used to perform 
statistical calculations (see the legend of the graph figures). Significance was accepted 
at p values ˂0.05. All were performed using software. Solvent and negative control were 
included in all experiments and values were compared by the Student’s unpaired t test. 
In all cases, comparison between these controls showed no statistically significant 
differences (p>0.5). 
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CHAPTER 2: RESULTS AND DISCUSSION 
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4.2.1. 2,4-Dinitrophenol (2,4-DNP) reduces cellular viability in primary rat 
hepatocytes 
Since the liver plays a fundamental role in the metabolism of xenobiotics, hepatocytes 
were of interest to be used in our study. In fact, by virtue of their central function in the 
metabolic fate of most exogenous and endogenous compounds, they are also of vital 
importance in the process of (de)toxification (Dias-da-Silva et al., 2015). Hepatocytes 
are composed of a set of enzymes that intervene in metabolization, a process that mostly 
occurs in two phases, phase I and phase II. Reactions of phase I involve the oxidation 
of compounds, resulting in more polar substances that then undergo phase II reactions. 
Phase II reactions imply the drug conjugation with endogenous molecules by 
glucuronidation, sulfation, methylation and acetylation (Gomez-Lechon et al., 2007). 
Most biotransformation processes to which xenobiotics and other endogenous 
compounds are subjected to, enable them to form more hydrophilic molecules that will 
facilitate their elimination from body. Hepatocytes have therefore been deemed of 
enormous importance as an in vitro tool for studying hepatotoxicity (Andersson, 2010), 
supporting our selection of primary rat hepatocytes as the cellular model for the current 
study. 
Primary rat hepatocytes were exposed to a comprehensive range of 2,4-DNP 
concentrations to enable complete cytotoxic profiles (concentration-dependent 
responses from 0% to 100% mortality). Cellular viability was then assessed by three 
different assays, the MTT reduction, the LDH leakage and the NR lysosomal 
incorporation assay. As shown in figure 22, the observed hepatocyte damage directly 
increased with the concentration of 2,4-DNP in all cell viability assessments performed 
herein. However, 2,4-DNP potency was different among the different tests. The most 
sensitive assays to 2,4-DNP were the MTT (EC50 96.8 µM) and NR (EC50 98.1 µM) 
assays, which induced very similar responses. On the other hand, the potency of 2,4-
DNP to cause cell death in the LDH assay (EC50 174.8 µM) was significantly lower 
(p<0.0001; F test), as higher concentrations of drug were necessary to induce the same 
level of toxicity. 
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The comparison of the obtained results provided information about the relative sensitivity 
of the target organelles, suggesting that the mitochondria was the most sensitive 
organelle to 2,4-DNP-induced toxicity, followed by lysosome and by the cytoplasmic 
membrane. Our data generally agrees well with what has been previously published for 
2,4-DNP in vitro cytotoxicity. In mesenchymal stem cells isolated from tibia and femur of 
Sprague Dawley rats, cells were slightly shrunken after 20 min-exposure at 250 µM and 
500 µM of 2,4-DNP, while at 1 mM and 2 mM almost all cells were dead (Ali et al., 2015). 
In a study conducted in hepatocytes isolated by collagenase perfusion of rat livers, it was 
observed that exposure at 300 µM of 2,4-DNP for 2 h was required to cause a 50% 
decrease in cell viability, as assessed by the trypan blue exclusion assay (Moridani et 
al., 2003). In another previous investigation also using the same time point and cellular 
model, only slight alterations on cell damage were produced in the presence of the 
uncoupler; nevertheless, concentrations used in this latter study were much lower than 
those used (up to 20 nmol per million of freshly isolated hepatocytes, which corresponds 
to 10 µM in our study) (Letko et al., 1990) 
Figure 22: Cell mortality induced by 2,4-dinitrophenol (2,4-DNP) in primary rat hepatocytes after 
24h of incubation at 37°C. Data were obtained in three distinct assays: neutral red (NR) uptake 
assay (data displayed in red), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumreduction (MTT) 
assay (data displayed in blue) and lactate dehydrogenase (LDH) leakage assay (data displayed 
in yellow), as indirect measures of cell viability. Data are presented as percentage of cell death 
relative to the respective negative controls and are from four independent experiments (performed 
in triplicate for each concentration within each experiment). Curves were fitted using the 
dosimetric Logit model. The dashed grey lines represent 50% and 100% effect. 
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For the sake of comparison with 2,4-DNP results, the cellular viability was also assessed 
by the MTT assay, after exposure to caffeine, Supplement 1 and Supplement 2 for 24 h. 
No toxicity was observed at the range of concentrations tested (from 10.7 µg/mL to 4.7 
mg/mL, for caffeine; from 228 ng/mL to 100 µg/mL, for Supplement 1 and Supplement 
2). This was probably due to the low concentrations used in our experiments. However, 
the testing of higher concentrations was precluded by the low solubility of these products. 
From the data obtained, we can only conclude that 2,4-DNP elicited higher toxicity than 
Supplement 1 and Supplement 2 (100 µg/mL 2,4-DNP corresponds to 543 µM, which 
elicits 93.58% effect in the MTT assay). 
 
4.2.2 2,4-Dinitrophenol (2,4-DNP) augments production of intracellular reactive 
oxygen (ROS) and nitrogen (RNS) species 
All further assays performed to elucidate the mechanisms responsible for the observed 
hepatotoxicity were conducted at four 2,4-DNP concentrations: 1 μM, 10 μM, 50 μM, 100 
μM and 200 μM. All these concentrations were lower than blood concentrations reported 
in fatally intoxicated individuals (<262.8 µM) (Politi et al., 2007). Therefore, even the 
highest concentration used in our study is of biological realistic relevance. 
The production of ROS/RNS and the resulting oxidative and/or nitrosative stress was 
evaluated through the incubation of primary rat hepatocytes with the DCFH-DA cell 
permeant, following 2,4-DNP incubations for 24 h. As depicted in figure 23, in general, 
ROS/RNS production increased with the increasing concentration of 2,4-DNP. At 1 µM 
and 10 µM 2,4-DNP already elicited an increase in ROS/RNS levels by 25%, but the 
drug-induced effect was only statistically significant (p˂0.01; ANOVA/Holm-Sidak’s) 
when 2,4-DNP was at ≥50 µM. Likewise, Han et al. (2008b) showed that intracellular 
H2O2 and O2-• production markedly increased in As4.1 juxtaglomerular cells, when cells 
were exposed at concentrations higher than 500 μM for 48 h. Studies focussing on 
measuring the impact of mild mitochondrial uncoupling in mice reported conflicting 
results. Accordingly, the authors observed a lower release of oxidants, compared to 
controls, in animals systemically treated with 2,4-DNP (doses ranging between 30–105 
μg/kg/day) and the prevention of ROS formation was accompanied by an improvement 
in the redox state (significant reductions in oxidation of deoxyribonucleic acid (DNA) and 
proteins in the brain, liver and heart, after treatment for five months) (Caldeira da Silva 
et al., 2008). 
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Several physiological processes that occur in cell can result in increased oxidant species 
generation, with consequent decrease of antioxidant protection, and ultimately failure to 
repair oxidative damage. Particularly, the mitochondrial respiratory chain is the main 
source of ROS/RNS production in the healthy cell. Besides aerobic respiration, 
cytochrome P450 metabolism is also a relevant source of prooxidant species. Eiseman 
et al. (1972) examined in vitro metabolism of 2,4-DNP in rat liver homogenates and 
concluded that 2,4-DNP was metabolized into the metabolites 4-amino-2-nitrophenol 
and 2-amino-4-nitrophenol. Scarce information on 4-amino-2-nitrophenol toxicity 
suggests safety concerns, particularly for potential carcinogenicity and mutagenicity of 
4-amino-2-nitrophenol (Burnett et al., 2009). In addition, these 2,4-DNP metabolites can 
enter into redox chain reactions, inducing massive formation of ROS (Eiseman et al., 
1972). Excessive production of ROS gives rise to activation of events, which can 
culminate in cell death (Han et al., 2008a). 
 
Figure 23: Reactive species (ROS/RNS) production, measured through the 2’,7’-
dichlorofluorescin diacetate (DCFH-DA) assay, in primary rat hepatocytes, after 24h of incubation 
with 2,4-dinitrophenol (2,4-DNP), at 37°C. Results are expressed as percentage of control ± 
standard error of the mean (SEM) from four independent experiments, run in triplicate. Statistical 
comparisons were made using one-way ANOVA/Dunnett’s post hoc test. **p˂0.01; ****p˂0.0001; 
versus control. 
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4.2.3 2,4-Dinitrophenol (2,4-DNP) disrupts intracellular thiol balance 
Since the cell has defence mechanisms against basal production of ROS/RNS, oxidative 
stress only occurs when there is an imbalance between the oxidants and the 
antioxidants, in favour of the former species. In this context, redGSH is an important 
antioxidant that is involved in many cellular processes, including antioxidant defence and 
drug detoxification (Franco et al., 2008). 
As referred, 2,4-DNP suffers hepatic metabolism into 4-amino-2-nitrophenol and 2-
amino-4-nitrophenol, and also into 2,4-diaminophenol, which are ROS/RNS generators 
(Eiseman et al., 1972). In addition to increased oxidative cellular status, redGSH 
depletion have also been considered a potential biomarker of drug-induced 
hepatotoxicity (Franco et al., 2008). Therefore, the evaluation of the redGSH and GSSG 
levels in primary rat hepatocytes exposed to 2,4-DNP was used to provide 
complementary information on the redox cell status. 
As shown in figure 24A, hepatocytes were significantly depleted of redGSH (a potent 
reactive species scavenger) when exposed at 100 µM (p˂0.01; ANOVA/Dunnett’s) and 
200 µM (p˂0.001; ANOVA/Dunnett’s) of 2,4-DNP. Additionally, a significant increase of 
GSSG was also observed for all concentrations. Cells exposed to high levels of oxidative 
stress, accumulate GSSG with reduction of the GSH/GSSG ratio, an evidence of 
oxidative stress. Accordingly, the results of our study on GSH and GSSG intracellular 
levels were consistent with the significant decrease of GSH/GSSG ratio (p˂0.001; 
ANOVA/Dunnett’s) after cell treatment with 2,4-DNP, observed for all concentrations 
(figure 24B). 
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4.2.4 2,4-Dinitrophenol (2,4-DNP) hyperpolarizes mitochondria, an effect that 
was concentration-independent 
The total force impelling protons into the mitochondrial matrix (i.e., Δp) is a combination 
of both Δψm (electrical gradient) and the mitochondrial pH gradient (ΔpHm, an H+ 
concentration gradient) (Perry et al., 2011). While Δp affords the energetic force required 
for ATP production, Δψm provides the electric gradient necessary for calcium 
sequestration in the organelle, and regulates production of ROS. 
2,4-DNP is a lipophilic weak acid that binds hydrogen ions in the intermembrane space 
of mitochondria, transferring protons back into the mitochondrial matrix by a shuttle-type 
mechanism and, consequently, dissipating the proton gradient across the mitochondrial 
membrane. For this reason, 2,4-DNP is considered an ‘uncoupler of oxidative 
phosphorylation’ (Hargreaves et al., 2016). Frequently, an increase in protons in the 
mitochondrial matrix (i.e., loss of the proton gradient) is accompanied by decreased Δψm 
(depolarization), as observed in Calu-6 and As4.1 cells after exposure to 2,4-DNP (Han 
et al., 2008a; Han et al., 2008b). However, contrarily to the expected, in primary rat 
hepatocytes, a significant increase in ΔΨm was observed at 10 µM and 50 µM of 2,4-
DNP (p˂0.05; ANOVA/Holm-Sidak’s), as shown in figure 25. 
Figure 24: (A) Intracellular contents of reduced (GSH, black bars) and oxidized (GSSG, white bars) 
glutathione and (B) intracellular GSH/GSSG ratio, in primary rat hepatocytes, after 24h of incubation with 
2,4-dinitrophenol (2,4-DNP). Results are expressed as mean ± standard error of the mean (SEM) from 
four independent experiments. Statistical comparisons were made using one-way ANOVA, Dunnett’s 
post hoc test. **p˂0.01; ***p˂0.001; ****p˂0.0001; versus GSH control. &p˂0.05; &&p˂0.01; &&&p˂0.001; 
&&&&p˂0.0001; versus GSSG control. $$$p˂0.001; $$$$p˂0.0001; versus GSH/GSSG control. 
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In line with our findings, in some conditions of intracellular stress, increased Δψm (more 
negative mitochondrial interior) occur parallel to increased proton concentration in the 
matrix (as that induced by 2,4-DNP) (Perry et al., 2011). In fact, when we assessed the 
charge gradient Δψm across the inner membrane by the TMRE assay, we did not 
evaluate the mitochondrial proton gradient, ΔpHm, or the respiratory status. Accordingly, 
hyperpolarization effects observed herein may be a consequence of dysregulation of 
intracellular ionic charges, such as increased cytosolic calcium, as already observed by 
other authors (Arbo et al., 2016). Alterations in cytosolic calcium levels may be induced 
by mitochondria and endoplasmic reticulum calcium overload and by modulation of 
calcium reuptake into these organelles. Interestingly, the perturbation of Δψm was not 
evident at the higher test concentrations, which could indicate that calcium overburden 
is an initial event of cell stress. This hypothesis awaits experimental confirmation through 
supplementary mechanistic studies. 
 
Figure 25: Mitochondrial membrane potential (ΔΨm) measured by the TMRE 
incorporation in mitochondria of primary rat hepatocytes after 24h of incubation with 
2,4-dinitrophenol (2,4-DNP), at 37°C. Results are expressed as percentage of 
control ± standard error of the mean (SEM) from four independent experiments, run 
in triplicates. Statistical comparisons were made using one-way ANOVA/Holm-
Sidak’s post hoc test. *p˂0.05; versus control. 
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4.2.5 2,4-Dinitrophenol (2,4-DNP) alters intracellular energetic stores 
Proton gradient across the mitochondrial membrane is of paramount relevance, since 
complex V requires the proton bypassing as electrochemical energy to synthesize ATP 
from ADP and Pi. Under these conditions, energy can not be created, which leads to a 
significant heat production and calorie consumption through stimulation of glycolysis 
(Hargreaves et al., 2016; Harvey et al., 2004). Some xenobiotics, such 2,4-DNP, that 
interfere with the mitochondrial breathing, may compromise the production of energy by 
the cell. Results from evaluation of intracellular ATP levels are represented in figure 26. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
When cells were treated with 10–100 µM of 2,4-DNP, ATP levels were significantly 
higher than control treatments. At the highest concentration of 200 µM cell energetic 
stores substantially decreased (p˂0.05; ANOVA/Dunnett’s). These results are in line with 
the mitochondrial hyperpolarization observed, which may lead to the conservation of ATP 
levels. In previous studies using human male germ cells, a decreased in ATP production 
was also observed when cells were treated with 2,4-DNP at 200 µM (Erkkila et al., 2006). 
ATP is used by all living organisms as a form of storage of metabolic energy and as a 
‘coin’ for every energy transfer. ATP generation by the F0F1-ATP synthase is crucially 
Figure 26: Intracellular ATP levels in primary rat hepatocytes after 24h of incubation 
with 2,4-dinitrophenol (2,4-DNP), at 37°C. Results are expressed as mean ± standard 
error of the mean (SEM) from four independent experiments. Statistical comparisons 
were made using one-way ANOVA/Dunnett’s post hoc test. *p˂0,05; **p˂0.01; 
****p˂0.0001; versus control. 
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dependent on an active respiratory chain. The respiratory chain generates a 
transmembrane potential (ΔΨm) across the inner mitochondrial membrane and, 
consequently, a proton concentration gradient (change in pH), which then provide energy 
for synthesizing ATP by the ATP synthase. Together, both ΔΨm and Δp help regulate 
mitochondrial control over energy metabolism, intracellular ion homeostasis and cell 
death. During cellular stress, Δψm may in turn be altered by dysregulation of intracellular 
ionic charges, consequently changing Δp and thus ATP production. When ionic fluxes 
surpass the ability of mitochondria to buffer these changes, ultimately Δp, Δψm, and/or 
ΔψpHm may collapse, leading to a failure of ATP production, energetic stress, and 
ultimately cell death. These could help justifying the observed decrease in ATP 
production, at the highest test concentration. 
The higher ATP levels observed at the lower 2,4-DNP tested concentrations may be 
explained by 2,4-DNP-induced increases in the glycolytic metabolism of glucose (Harvey 
et al., 2004). 
 
4.2.6 2,4-Dinitrophenol (2,4-DNP) activates extrinsic, intrinsic, and common 
apoptosis pathways 
The mechanism of apoptosis involves mainly two signalling pathways, the mitochondrial 
pathway (intrinsic pathway) and the cell death receptor pathway (extrinsic pathway). The 
key element in the mitochondrial pathway is the efﬂux of cytochrome c (an essential 
component of the electron transport chain) from mitochondria to cytosol, where it 
subsequently forms a complex (apoptosome) with Apaf-1 and caspase-9, leading to the 
activation of the caspase-3. The cell death receptor pathway is characterized by the 
binding of cell death ligands to cell death receptors (McIlwain et al., 2013), and by 
activation of caspase-8 and subsequently caspase-3 (Han et al., 2008b). In this case, 
cell death stimuli is originated from the exterior of the cell following, for instance, drug-
induced injury. Both cleavage of pro-caspase-8 (activation of extrinsic apoptotic 
pathway) and pro-caspase-9 (activation of intrinsic apoptotic pathway) induce the 
activation of the common apoptotic pathway (cleavage of pro-caspase-3). 
As can be seen in figure 27, a significant increase in caspase-8 activity (figure 27A) 
occurred in primary rat hepatocytes exposed for 24h at all concentrations tested of 2,4-
DNP. The activity of this caspase was maximal when cells were treated with 50 µM of 
2,4-DNP (p˂0.0001; ANOVA/Dunnett’s). For caspase -9 (figure 27B) and -3 (figure 27C), 
the activation was concentration-dependent and occurred only at higher concentrations, 
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as significant differences to controls were verified only from 10 µM on (p˂0.05; 
ANOVA/Dunnet’s). 
 
 
Of interest, the intracellular energetic increase was only significant at concentrations 
between 10 µM and 100 µM, which could justify the higher activation of caspases at this 
concentration levels, since apoptosis involves many energy-dependent processes.  
Han et al. (2008a; 2008b) showed that 2,4-DNP induced apoptosis in As4.1 
juxtaglomerular and Calu-6 cells in a dose-dependent manner. In both these cell lines, 
treatment with low doses of 2,4-DNP (≤1 mM) induced a G1 phase arrest of the cell cycle 
after 72 h of exposure. At higher concentrations (2–4 mM), 2,4-DNP induced apoptosis 
without a specific arrest of the cell cycle (Han et al., 2008a). Interestingly, in As4.1 cell 
studies, Han et al. (2008b) observed activation of caspase-9 but not caspase-8. 
Apoptosis via the mitochondrial pathway may increase the permeability of mitochondrial 
membrane (permeability transition), leading to the leaking of important mitochondrial 
intermembrane factors to the cytosol, where these proteins activate later apoptotic 
cascades (common apoptotic pathway through caspase-3 cleavage) and the 
apoptosome formation (Nicholls, 2002). 
 
  
Figure 27: Caspase-8, -9 and -3 activities in primary rat hepatocytes after 24h of incubation with 2,4-
dinitrophenol (2,4-DNP), at 37°C. Results are expressed as percentage of control ± standard error of 
the mean (SEM) from four independent experiments. Statistical comparisons were made using Kruskal-
Wallis one-way analysis of variance/Dunnett’s post hoc test. *p˂0.05; **p˂0.01; ***p˂0.001; 
****p˂0.0001; versus control. 
 
Figure 28: Caspase-8, -9 and -3 activities in primary rat hepatocytes after 24h of incubation with 2,4-dinitrophenol 
(2,4-DNP), at 37°C. Results are expressed as percentage of control ± standard error of the mean (SEM) from four 
independent experiments. Statistical comparisons were made using Kruskal-Wallis one-way analysis of 
variance/Dunnet’s post hoc test. *p˂0.05; **p˂0.01; ***p˂0.001; ****p˂0.0001; versus control. 
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PART 5 – CONCLUSION 
 
The effects of 2,4-DNP on weight loss and its easy access have increasingly attracted 
people looking for supplementation with ‘fat burners’, particularly those seeking to 
combine a healthy lifestyle with diet or the practice of sport. Several competent regulators 
banned the human consumption of this 2,4-DNP as soon as the first reports of 
intoxication began to appear. However, the frequent existence of fraudulent labelling and 
advertising along with the easy access through internet, make 2,4-DNP consumption a 
reality that remains. 
The development of analytical methods that quickly allow the detection and identification 
of this substance in commercial products is therefore of utmost importance both for 
forensic and clinical purposes. The work conducted herein concerning the chemical 
identification of the components included in two dietary supplements commercialized as 
‘fat burners’ (Supplement 1 and Supplement 2) revealed the absence of 2,4-DNP, 
suggesting that these new formulations are free from this toxic component. However, 
some other compounds were able to be identified in these formulations namely caffeine, 
glycerol, fatty acids and fatty acid derivatives (including 2-palmitoylglycerol or glycerol 
monostearate) and sugars (glucose, sucrose and lactose) as the main constituents. 
Regarding caffeine, this compound is one of the most commonly detected in this type of 
products and was also present at high concentrations in our both tested products. Of 
concern, we noticed that for Supplement 2 users, the daily supplementation with caffeine, 
considering the amount contained in the product and the daily dose indicated by the 
manufacturer, far exceeds the recommended daily limit for the substance (approximately 
400 mg versus 848 mg of caffeine per day). The high diversity in the composition of these 
products, which includes plant extracts, amino acids, carnitine, fatty acids, polyphenols 
among others, is one of the greatest problems associated with these ‘fat burner’ 
products. The consumers cannot be sure of what they are ingesting due to the unspecific 
information containing in the labels. Accordingly, labelling problems have been reported 
in many supplements available and all too often these products are adulterated with 
mixtures of other substances. 
Information on the effects of 2,4-DNP mainly derive from the intoxication cases reported 
by the emergency care units, and there is no specific antidote or treatment. Although we 
did not find 2,4-DNP in our tested products, in-depth toxicological investigations on 2,4-
DNP effects are essential to alert the target public to the harm of consuming these 
products, particularly because over the last decade there has been an increasing on its 
demand, interest and use, mainly due to all divulgation through the online market. In this 
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regard, we proved in this work that the consumption of weight loss products containing 
2,4-DNP may produce toxicological effects, since the substance exhibited a 
concentration-dependent decrease in cell viability of the primary hepatocytes isolated 
from Wistar rats, at 37° C for 24 h, as assessed by three different in vitro bioassays [NR 
uptake assay EC50 98.05 µM; MTT assay EC50 96.82 µM; and LDH leakage assay EC50 
174.83 µM]. These results indicate that the mitochondria was the most sensitive 
organelle to 2,4-DNP-induced toxicity, followed by lysosome and by the cytoplasmic 
membrane. In addition, our results, revealed that 2,4-DNP accelerates hepatocellular 
metabolism through instigation of ATP formation at the mitochondria, at low 
concentrations (up to 1 µM). This effect might be responsible by the observed oxidative 
burst, concurrent to a concentration-dependent decline in antioxidant defenses, that in 
turn could activate cell death signalling pathways through intrinsic and extrinsic pro-
apoptotic mechanisms. This toxicological information is crucial to reinforce the dangers 
associated with 2,4-DNP as a substance used for weight loss. 
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